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The development of the central nervous system requires the orchestration of 
numerous instructive and permissive cues. These factors are secreted from 
signaling centers and function in a concentration dependent manner that effects 
the proliferation, survival and differentiation of neural progenitors (NP) and their 
differentiated progeny. The family including bone morphogenetic proteins (BMPs) 
are key regulators of NP expansion and survival. However, once NP become 
committed to a neuronal fate and begin to differentiate they compete for limited 
amounts of neurotrophin that facilitate further growth and survival. Here we show 
that the p75 neurotrophin receptor interacting protein NRAGE is expressed in NP 
of the developing cortex during the peak period of progenitor apoptosis. This 
NRAGE dependent apoptosis of NP cells is mediated through the BMP TAKI- 
TABI-XIAP signaling complex leading to the activation of p38. The combined 
BMP activation of p38 and Smad signaling adversely effects the terminal 
differentiation of NPs into neurons. These results demonstrate the conserved 
nature of progenitor and trophic dependent apoptosis through the utilization of 
NRAGE and common cell death machinery highlighting the important 
mulitfunctionality of NRAGE during neurogenesis. 
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CHAPTER 1 
Introduction to Apoptosis and Developmental Neurobiology. 
Morpholoqical Types of Cell Death. 
It has been proposed that there are three main types of cell death during 
normal development, on the basis of the role of the lysosomes in cell disruption'. 
In the first type, cell death occurs without any detectable activities of endogenous 
lysosomes and secondary lysosome activation by tissue macrophages. This 
process has been referred to as heterophagocytosis. In the second type of cell 
death, autophagocytosis cells are eliminated after activation of their own 
lysosomal enzymes. In the third type, there is no obvious lysosomal intervention. 
The first types are by far more common and have been described by various 
authors2. 
Apoptosis. 
Apoptosis was originally defined as a distinct mode of cell death on 
the basis of a series of characteristic ultrastructure features according to the 
following sequence of events: nuclear and cytoplasmic condensation, cell 
fragmentation and phagocytosis3. However, more recent attempts to characterize 
apoptosis have included cell dehydration, cell membrane changes, condensation 
of nuclear chromatin, disintegration of the nuclear envelope, mobilization of 
intracellular ionized calcium, a decrease of the mitochondria1 transmembrane 
potential, activation of caspases, and internucleosomal DNA cleavage. 
Therefore, a wide spectrum of methods has been developed to assess and 
quantify apoptosis in biological systems. Late apoptotic events such as DNA- 
strand breaks can be assessed by terminal deoxynucleotidyl transferases (TdT) 
assays or nuclear DNA fragmentation of cells with sub G I  DNA content. More 
recently redistribution of the phospholipid phosphatidylserine (PS) from the inner 
plasma membrane leaflet to the outer leaflet has been used to determine early 
apoptotic events4. Following apoptotic cell fragmentation into membrane-bound 
bodies macrophages or neighboring cells rapidly clear out and degrade apoptotic 
bodies within heterophagosomes. 
The process of apoptosis plays an essential role in sculpting parts of the 
body. The formation of digits in some higher vertebrates is a well-studied 
example, where apoptosis eliminates the cells between developing digits5-'. 
Similarly, apoptosis is involved in hollowing out sold structures to create lumina. 
In the early mouse embryo, for example the preamniotic cavity is formed by the 
death of ectodermal cells in the core of the developing embryo8. Apoptosis also 
occurs wherever epithelial sheets invaginate and pinch off to form tubes or 
vesicles, as in the formation of the neural tube, lens and mammalian palateg. 
In the course of animal development, various structures are formed that 
are later removed by apoptosis. These include transient structures that are 
needed at one developmental stage but not at a later or structures required in 
one sex but not the other1'. However, one of the most perplexing phenomena 
,that involve apoptosis is the overproduction of cells within a given tissue and then 
subsequent culling by apoptosis to adjust their numbers. In the vertebrate 
nervous system both neurons and oligodendrocytes are generated in excess with 
a large percentage being eliminated by programmed cell death11312. Although the 
influence of cell proliferation in controlling cell numbers in animal development 
has received more attention the influence of apoptosis may very well be a 
dominant mechanism an its role during neurogenesis is an important new 
frontier. 
Cell Death in  Early Neural Development. 
Programmed cell death is a highly phylogenetically conserved mechanism 
by which eukaryotic cells die following a stereotypic series of molecular and 
cellular events commonly referred to as a p o p t o s i ~ ~ ~ ~ ~ .  Apoptosis has been 
recognized to be an essential process during development where it appears to 
be fundamental for the control of the final numbers of neurons and glia in the 
central nervous system (CNS) and peripheral nervous system (PNS). Moreover, 
a growing body of evidence indicates that apoptosis is also responsible for the 
14,15 loss of neurons associated with physiological aging . 
Nearly all classes of neurons are produced in excess during development 
and it has been postulated that approximately half die before the completion of 
the CNS'~. These large populations of neurons are then significantly reduced 
during the periods of naturally occurring neuronal death, primarily through 
activation of the apoptotic machinery. The neurotrophic theory clearly establishes 
the role of target-derived neurotrophic factors in the protection of projecting 
neurons from programmed cell death. The neurotrophic theory provides a 
conceptual base for the acceptance of cell death as a physiological process in 
neural development, but also to generalize the significance of cell death during 
normal development in an 
Still, the general idea beyond this expanded concept is that naturally 
occurring neuronal death is closely related to the establishment of proper 
connections with their target, and under this perspective little attention has been 
dedicated to apoptosis of neural precursors andlor young neuroblasts at early 
developmental stages, which seems to be independent from synaptogenesis. 
Early Death of Proliferating Precursor Cells. 
It is generally believed that a correct balance between cell 
proliferation and apoptosis during development is fundamental to determining the 
ultimate structure, architecture, size, and shape of tissues and organs. The 
existence of naturally occurring cell death in the neuroepithelium at the beginning 
of neurulation was first described more than 50 years agog. Since then early 
neural death has been described during the formation of neural crest, and 
neurogenesis, with a widespread distribution through out the CNS and in PNS 
In these early developmental stages, differentiated neurons are 
rare, if not totally absent. Therefore, although a quantitative contribution of early 
progenitor apoptosis has been elusive, it is reasonable to assume that they must 
be proliferating neural precursors or newly generated neuroblasts and not 
functional neurons connected to their targets. 
Studies utilizing knockout mice studies have provided dramatic proof of 
the occurrence of cell death during early neural vertebrate development in which 
activation of several regulatory or executor molecules in the apoptotic pathway 
caused embryonic or perinatal Unexpectedly, the CNS was the most 
affected tissue, presenting a large excess of neurons in disorganized structures. 
Morphological defects were already visible well before neuronal generation, as 
early as embryonic day (E) 9.5 in the null mutant for the apoptotic activator Apaf- 
and at E l  0.5 in the null mutants for caspase-932 and caspase-333. 
Since proliferation, differentiation and apoptosis are concurrent processes 
during early neurogenesis, determination of the relationship between proliferation 
and apoptosis of individual cells is an important issue to be assessed. 
Interestingly, a number of studies led to the conclusion that apoptotic cells enter 
the cell cycle shortly before Making the relationship between cell 
cycle control and apoptosis a vital mechanism in controlling cell fate. 
Neural Apoptosis at Cell Cycle Checkpoints. 
The cell cycle apparatus is composed primarily of three families of 
proteins: the cyclin-dependent protein kinases (CDKs), the cyclins and the cyclin- 
dependent kinase inhibitors ( ~ ~ 1 s ) ~ ~ ~ ~ ~ .  CDKs allow progression through the 
different phases of the cell cycle by phosphorylating critical serines and 
threonines on their target substrates. Their kinase activity is dependent on the 
presence of activating subunits known as cyclins, whose abundance varies 
substantially during the cell cycle. D-type cyclins are rapidly turned over and are 
synthesized in response to mitogenic stimuli. Once synthesized, they associate 
with CDK4 and CDKG, forming active CDK complexes in early G1 phase40141. In 
midllate G I ,  cyclin E is induced and forms complexes with CDK2, whose activity 
appears essential for entrance into S phase42s43. Cyclin A activity appears in 
concert with the onset of DNA synthesis and it initially partners with CDK2 and 
later with C D C ~ ~ ~ ~ ~ ~ .  For mitosis to occur, cells must progress through the G2lM 
transition, which requires the assembly of the maturation-promoting factor (MPF) 
that is composed of cyclin B and CDC2. At late G2, MPF induces its own demise 
by activating the mitotic cyclin destruction system through the anaphase- 
promoting complex (APC), which acts as a ubiquitin E3 ligase for MPF. 
Two major classes of CKls have been identified. The first is the Kip family 
of inhibitors that consists of p21Waf1, ~ 2 7 ~ ~ ~ '  and ~ 5 7 ~ ' ~ ~ .  These three CKls can 
bind to most cyclin-CDKs and inhibit their a ~ t i v i t i e s ~ ~ - ~ ~ .  The Kip family of 
inhibitors share a common N-terminal domain for binding to and inhibiting the 
kinase activity of CDK-cyclin complexes. The second family of CKls consists of 
the INK4 family of inhibitors, which includes p16 INK4al p1 51NK4b, p1 81NK4~, and 
~ 1 9 ' ~ ~ ~ ~ .  INK4 proteins are a group of ankyrin repeat-containing proteins, which 
specifically bind to and inactivate CDK4 and CDK6 by preventing their bindings 
49,50 tothecyclins . 
The orderly progression of the cell cycle is driven by sequential activation 
of CDKs to pass key restriction or primarily during the GIIS and 
G21M transition of the cell cycle. The checkpoints of the cell cycle ensure that 
critical events in a particular phase are completed before the next phase can be 
initiated, thereby ensuring genome integrity. Frequently, cells decide to enter or 
withdraw from the cell cycle at the G I  phase, and thus the G I  checkpoint at the 
GI/S transition is often a prime target for cell cycle regulation. Cell cycle 
progression can be blocked at the G I  checkpoint in response to the status of 
both the intracellular and extracellular environments. 
G I  phase is a period when cells make critical decisions about their fate, 
including the option to replicate DNA and complete cell division. The decision to 
enter the S phase is made at the so-called restriction point in mid-to-late ~ 1 ' ~ .  
The genes critical for Gl /S transition and coordination of S-G2-M progression are 
regulated by the parallel retinoblastoma protein (Rb) and Myc pathways54. 
Retinoblastoma Protein Family. 
Among the best-characterized substrates of G I  CDKs are Rb and 
the Rb-related proteins p107 and p13055-57. Each of these Rb family members is 
capable of blocking progression from G I  into s ~ ~ - ~ ~  suggesting some functional 
redundancy amongst Rb family members. When hypophosphorylated, Rb is 
active and able to bind to and repress transcription factors that promote 
proliferation, most notably, the E2F family of transcription factors. 
Phosphorylation primarily through CDK activity inactivates Rb, thereby releasing 
these transcription factors and driving S phase progression. Rb-deficient 
embryos display numerous abnormalities in the nervous system, which occur 
shortly after the time at which Rb would normally be expressed. In ~ b - ' -  null mice 
ectopic mitosis is observed in various brain regions and massive cell death 
occurs throughout the CNS and P N S ~ ~ - ~ ~ .  A transient increase in Rb protein 
levels appear to be an important step in the initiation of terminal mitosis of 
neuronal progenitors, and is then followed by drastic reduction during terminal 
differentiation and maintained at low levels in postmitotic neurons67s68. Moreover, 
an increasing body of evidence is leading to the notion that postmitotic neurons 
generally undergo apoptosis when the cell cycle regulators that promote Rb 
phosphorylation are activated. In support of this, E2F family members can trigger 
apoptosis, and E2F1 -induced apoptosis can be specifically inhibited by ~ b ~ ' .  
High levels of E2F1 in a cycling cell signals division, in a quiescent cell such as a 
postmitotic neuron, the potent contradictory growth signals of E2F1 above a 
critical concentration may trigger the apoptotic cascade. The E2F1-mediated cell 
death of neural progenitors appears due to Rb-inactivation and was shown to be 
p53-dependent70771. 
Death of Postmitotic Neurons. 
Neurotrophins and Neuronal Survival. 
Death of postmitotic neurons is a widely recognized phenomenon 
that plays a crucial role in sculpting and maintaining the architecture of the 
mature nervous system. A relatively large apoptotic loss of different types of 
neurons (and glial) occurs during vertebrate development, and the general 
explanation for this phenomenon is that survival of nerve cells depends on 
72-74 specific neurotrophic factors which are synthesized by their targets . 
Therefore, although many neuronal types are produced in excess, only a portion 
of them receives sufficient proper support for survival. 
Nerve growth factor (NGF) was the first in a family of small soluble 
molecules demonstrating survival effects on populations of mature neurons both 
in vitro and in vivo. The effects of these neurotrophic molecules are mediated 
through two distinct classes of receptors. One class consists of members of the 
Trk family of tyrosine kinase receptors while the other is made of a single 
member, ~ 7 5 ~ ~ ~ .  Decades of biochemical analyses have resulted in great strides 
towards understanding NGF signaling potential through Trk and recently through 
~ 7 5 ~ ~ ~ .  I began my studies attempting to understand the biological and signaling 
potential of by examining the expression and role of interacting 
proteins. My studies culminated with the discovery that one such interacting 
protein, NRAGE is expressed in a wide variety of tissues throughout 
development in a tight temporally regulated manner. 
Neurotrophins and Neurotrophin Signaling. 
The neurotrophins are a family of structurally related proteins. Four 
neurotrophin genes have been identified in both mouse and humans. Each gene 
codes for secretory proteins sharing four hallmark characteristics: (i) biosynthesis 
as precursor proteins, (ii) characteristic spacing between their six cysteine 
residues, (iii) highly basic isoelectric points, and (iv) the formation of non- 
72-77 covalently bound homodimers . Following the discovery of nerve growth factor 
(NGF)~~,~ ' ,  binding studies with radiolabeled NGF suggested the presence of two 
different receptors on responsive cells: one with high affinity and slow kinetics of 
association/dissociation and one with relatively low affinity and fast kineticsB0. 
The gene encoding for the low-affinity NGF receptor was the first NGF receptor 
to be cloned. Moreover, the primary sequence of its cytoplasmic domain did not 
indicate any catalytic activity, nor was this receptor sufficient to account for the 
physiological survival effects mediated by NGF~' ,~* .  Following the identification of 
brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and neurotrophin 
415 (NT4/5), these neurotrophins were also shown to bind to ~ 7 5 ~ ~ ~  with affinities 
similar to that of NGF (about lom9 M), but with relatively slower  kinetic^'^‘^^. This 
observation lead to a nomenclature change for the low-affinity NGF receptor to 
reflect its wide range of physiological relevant ligands. The low-affinity NGF 
receptor is now commonly referred to as p75 neurotrophin receptor ( ~ 7 5 ~ ~ ~ ) .  
After the initial biochemical characterization of p75NTR, it was 
demonstrated that the proto-oncogene TrkA (tropomyosin-related kinase) had an 
expression pattern in the developing nervous system suggestive of a potential 
role in neural development. It was hypothesized that TrkA may mediate long-term 
NGF survival87. Independent studies soon demonstrated that TrkA bound NGF 
resulting in the activation of its intrinsic tyrosine kinase promoting long-term 
Kinetic and binding experiments demonstrated that this second NGF 
receptor binds NGF with high-affinity75. One family of highly related tyrosine 
kinase receptors is now recognized in mammals, each receptor selectively 
binding its cognate neurotrophin(s) inducing dimerization bring their 
cytoplasmically located tyrosine kinase activities into proximity, thereby inducing 
them to cross-phosphorylate. Each receptor, TrkA, TrkB, and TrkC, is expressed 
in distinct parts of the nervous system and in several i s o f o r m ~ ~ ~ * ~ ~ .  NGF is the 
preferred ligand for TrkA, BDNF and NT415 are preferred for TrkB, and NT3 for 
~ r k ~ ' * .  Ligand binding triggers receptor dimerization, autophosphorylation, and 
activation of well-characterized signal transduction pathways that includes 
phosphatidylinositol 3 kinase, phospholipase C, and the RasIMAP kinase 
93,94 cascade . 
A plethora of experiments have demonstrated that the Trks mediate 
s u r v i v a ~ ~ ~ ~ ~ ~ ,  p r o l i f e r a t i ~ n ~ ~ ~ ~ ~ ~ ~ ~ ,  overt differentiation 100-102, synaptic plasticitylo3- 
'05, dendritic and axonal ~ p r o u t i n g ' ~ ~ - ~ ~ ~ ,  neurotransmitter expression and long- 
term p~tent iat ion'~~- ' '~.  However, some of the most convincing evidence comes 
from the tight correlation between the nature and the extent of neural losses after 
deletion of either a Trk receptor or its corresponding neurotrophin gene1'*. 
Neurotrophin Withdrawal and Apoptosis. 
The first neurotrophin-activated signaling protein shown to mediate 
survival of neurons was the small GTP-binding protein Ras. Inhibition of Ras 
activity decreased of survival many neuronal p ~ p u l a t i o n s ' ' ~ - ~ ~ ~ .  Ras, which in 
most cases is responsible for 40-60% of neurotrophin-dependent survival, does 
not act directly to promote survival. Rather, it functions by translating and 
directing neurotrophin-initiated signals into multiple signaling pathways. 
Numerous studies indicate that the two signaling pathways, PI-3WAkt and 
MEWMAPK, are the major effectors of neurotrophin and Ras-activated survival. 
PI-3K was first identified as a regulator of neurotrophin mediated survival 
responses by Cooper and colleagues in NGF-dependent PC12 cells"5. 
Subsequently, many groups showed that PI-3K activity was responsible for as 
much as 80% of neurotrophin regulated cell survival in cortical, cerebellar, motor, 
sympathetic and sensory  neuron^"^-'^^. Ras was shown to activate PI-3K 
survival promoting pathways through common effector proteins. Ras is not, 
however, the only means by which Trk activates PI-3K. In the Trk system, PI-3K 
activation is due to the corrtbined actions of Ras and Gab-I 127,128. The primary 
target for active PI-3K appears to be the serinelthreonine kinase ~ k t ~ ~ ~ ~ ~ ~ ~ .  Akt 
promotes its pro-survival activity through the phosphorylation of Bad that 
facilitates an association with 14-3-3, preventing it from binding and inactivating 
the anti-apoptotic protein Bcl-2 and Bcl-XL 131,132. Another potential target of PI-3K 
is the IAP (inhibitor of apoptosis) family of caspase inhibitors, which include X- 
linked inhibitor of apoptosis (XIAP), neuronal apoptosis-inhibitory protein (NIAP), 
and human inhibitor of apoptosis protein (HIAP) that function through inhibitory 
associations with procaspase-9133. 
Neurotrophin withdrawal reduces the activity of PI-3K permitting BH3 
containing proteins, such as Bad and Bcl-2, form a mitochondria1 pore increasing 
cytochrome c release and the activation of procaspase-9, which serves as a 
convergence in molecular pathways of apoptosis signaling formation of the 
apoptosome with subsequent cleavage of caspase-3 to the active form providing 
an unfettered route to apopt~sis'~. 
Although the role of the Trk receptors has continued to be thoroughly 
investigated and the function of the other neurotrophin receptor, p75NTR, has 
been more difficult to ascertain due to its lack of any obvious intrinsic catalytic 
activity or signaling domains. Complicating the issue, p7kjNTR is often co- 
expressed with at least one Trk receptor family member, making independent 
study of ~ 7 5 ~ ~ ~ - m e d i a t e d  effects difficult. However, recent studies indicate that 
does in fact have intrinsic signaling functions as described below. 
~ 7 5 ~ ~ ~  as a Death Receptor. 
In addition to the ability of ~ 7 5 ~ ~ ~  to modulate the binding and 
function of Trk receptors, this receptor has unique functions when expressed in 
the absence of Trk. The identification of p75NTR as a member of the TNF receptor 
superfamily suggests that ~ 7 5 ~ ~ ~  might signal cells to die, possibly using an 
analogous mechanism to TNF signaling. The first demonstration that ~ 7 5 ~ ~ ~  
could mediate apoptosis was by Rabizadeh and co~leagues '~~ in two distinct 
neural cell lines. Since then, a wealth of in vitro evidence has accumulated to 
support an apoptotic role for ~ 7 5 ~ ~ ~ .  Ligand mediated Trk independent apoptosis 
has been shown in a variety of neural cells that include sensory neurons 135,136 I 
sympathetic neurons'37, motoneurons '388139 and hippocampal neurons140. ~ 7 5 ~ ~ ~  
expression is not limited to neurons; in fact oligodendrocytes and Schwann cells 
also express ~ 7 5 ~ ~ ~  and have been shown to undergo an NGF-dependent 
~ 7 5 ~ ~ ~ - r n e d i a t e d  a p o p t ~ s i s ' ~ ' ~ ' ~ ~ .  
In vivo evidence for ~ 7 5 ~ ~ ~ - m e d i a t e d  cell eath has been found for two 
different central nervous system (CNS) populations. Early retinal and basal 
forebrain cells express ~ 7 5 ~ ~ ~ .  These cells undergo apoptosis, an effect that can 
be blocked by NGF ant ib~d ies '~~.  In cholinergic neurons of the basal forebrain 
there is a reduction in .the number of apoptotic cells in mice lacking the p75NTR 
receptor'44. Further evidence suggesting that ~ 7 5 ~ ~ ~  independently regulates 
cellular apoptosis comes from transgenic mice over-expressing the intracellular 
domain of p75NTR, resulting in a significant reduction in numbers of syrr~pathetic 
and sensory neurons as well as cell loss in the n e o ~ o r t e x ' ~ ~ .  The deficit in the 
peripheral nerves of these mice is primarily restricted to ur~myelinated axons 
indicating that cell death was confined to those sensory neurons that are 
normally receptive to NGF and which express TrkA. Cell death occurred in 
neocortical cells, which do not express TrkA. This argues against a dominant 
negative effect; whereby, pairing of the ~ 7 5 ~ ~ ~  intracellular domain with TrkA 
might lead to cell death by blocking the formation of high affinity receptors for 
NGF. These studies suggest that the ~ 7 5 ~ ~ ~  intracellular domain independent of 
Trk initiated the cell death process. Moreover, in ~ 7 5 ~ ~ ~  knockout mice, the 
number of sympathetic neurons at two weeks of age was significantly higher than 
wild-type mice, indicating that apoptosis was reducedq3'. ~ 7 5 ~ ~ ~  knockout mice 
were also reported to display reduced apoptosis, as detected by TUNEL, of 
spinal cord neurons at E l  1.5, and retinal neurons at ~ 1 5 . 5 ' ~ ~ .  
Isolation of Neurotrophin Receptor Interacting Factors. 
In general, it seems that neurotrophins can only induce cell death 
through ~ 7 5 ~ ~ ~  in cells not expressing their specific Trk receptors 137,146 
- BY 
contrast, coactivation of ,the appropriate Trk receptors inhibits neurotrophin- 
induced p75NTR-mediated apoptosis, as demonstrated with cultured 
oligodendrocytes and neuronsq36. A number of interactors and their possible 
functions have been described for p75NTR, many of them as a result of yeast two- 
hybrid screens. ~ 7 5 ~ ~ ~  interactors involved in transducing cell death include a 
wildly expressed zinc finger protein designated N Rl F (neurotrophin yeceptor- 
jnteracting NRlF knockout mice showed reduced levels of apoptosis in 
the retina, and this reduction was quantitatively similar to that seen in p75NTR null 
mice. These results suggest that NRlF is an essential component downstream of 
NTR- NGF and ~ 7 5 ~ ~ ~  in the cell death pathway. A protein designated NADE (p75- 
associated cell death executer) associates with ~ 7 5 ~ ~ ~  after NGF binding but not 
- 
NTR- after binding of BDNF, NT3 or ~ ~ 4 1 5 ' ~ ' .  It too seems to be involved in p75- 
mediated apoptosis. 
Another zinc finger protein that has been identified as an intracellular 
interactor of p75NTR, the Schwann cell factor-1 (SC-I), is involved in cell cycle 
arrest14'. SC-1 translocates from the cytoplasm to the nucleus after NGF, but not 
BDNF, stimulation of transfected COS cells. Nuclear expression of SC-1 led to 
loss of BrdU incorporation indicating a reduction in the rate of proliferation. The 
GTPase RhoA has been isolated as a ~ 7 5 ~ ~ ~  interactor in a yeast two-hybrid 
screenl5'. ~ 7 5 ~ ~ ~  constitutively activates RhoA, whereas neurotrophin binding to 
~ 7 5 ~ ~ ~  blocks this activation. The link to ~ 7 5 ~ ~ ~  and RhoA seems to be 
functionally relevant, as the modulation of neurite outgrowth in ~ 7 5 ~ ~ ~ - e x p r e s s i n g  
neurons by neurotrophins mimics the results obtained following RhoA 
inactivation. Using coimmunoprecipitation and phosphorylation assays, a p75 NTR- 
associated kinase15', as well as ERKI and E R K ~ " ~ ,  were shown to interact with 
~ 7 5 ~ ~ ~ .  The functional significance of these associations is not clear, though 
~ 7 5 ~ ~ ~  is serine phosphorylated in the intracellular domain. Association of 
TRAF6 with ~ 7 5 ~ ~ ~  after ligand binding leads to the activation of NF-KB'~~.  
Another report suggests that all members of the TRAF family interact with 
~ 7 5 ~ ~ ~ ' ~ ~ .  A further recently identified interactor of p75NTR, designated NRAGE 
(neurotrophin receptor-interacting MAGE), or MAGE-Dl, mediates NGF- 
dependent apoptosis in sympa,thetic neuron precursor cells155. NRAGE also 
causes cell cycle arrest when over-expressed in cultured cells, suggesting that 
~ 7 5 ~ ~ ~  might play a role in growth control throl~gh interactions with NRAGE. 
Interestingly, NRAGE disrupts the interaction between ~ 7 5 ~ ~ ~  and ~ r k ~ ' ~ ' .  The 
functional interactions between NRAGE and ~ 7 5 ~ ~ ~  are discussed in greater 
detail below. 
There remain many pertinent issues to address before a coherent view on 
naturally occurring neuronal cell death can be formed. However, evidences from 
transgenic and cell culture studies have delineated a picture in which a dual 
wave of apoptosis occurs. Early neural death of proliferating progenitors and 
young neuroblasts is assuming a more detailed contour, and an in depth analysis 
of the spatial, temporal and molecular links of proliferation, differentiation or 
apoptosis will surely be informative to better clarify the physiological role of this 
phenomena. Recently members of the bone morphogenetic family have been 
found as prominent regulators holding key roles during neural development 
including the regulation of neuronal and astrocytic determination and apoptosis in 
the cortex 7-10 and instructive cell fate decisions in the neural crest 11-15. 
Early Corticoqenesis. 
Regionalization of the neural plate and early tube is controlled by secreted 
molecules produced by a grid of patterning centers 156-1 59 . Longitudinal pattering 
centers are present along the ventral (axial mesoderm, and later the floor plate) 
and dorsal (epidermal-neuroectodermal limits and latter the roof plate) aspects of 
neural plate and early neural tube. Transverse patterning centers are present at 
specific anterior posterior locations such as the rostral end of the neural plate 
(anterior neural ridge, A N R ) ' ~ ~ ~ ' ~ '  and at the midbrain-hindbrain boundary 
( i~ thrnus) '~~.  Each patterning center produces a distinct set of signals. Ventral 
centers produce sonic hedgehog (shh) and B M P S ' ~ ~ - ' ~ ~ ;  dorsal centers produce 
BMPs and ~ n t s ' ~ ~ * ~ ~ ~  and transverse patterning centers produce fibroblast 
growth factor (FGF) and ~ n t s ' ~ ~ ~ ' ~ ~ ~ ~ ~ ~ .  Thus, the neuroepithelium adjacent to 
transverse and longitudinal patterning centers are exposed to a corr~bination of 
signals. While some insights into the combinatorial effects of extracellular signals 
on cellular fate of neuroepithelial progenitors has been made, little is known how 
combinations of these signals regulate cell proliferation, survival and 
differentiation in the CNS. Furthermore, less is known how these patterning 
centers are established and how they affect each other. 
Soon after folding of the neural plate into the neural tube, two pairs of 
large vesicles evaginate from its walls. First, the optic vesicles grow from a 
region near its rostral end, and give rise to the neural retina, pigment epithelium 
and optic stalks. Then, the telencephalic vesicles grow from the rostrodorsal part 
of the prosencephalon, and give rise primarily to the cerebral cortex and basal 
ganglia17'. Neural and non-neural tissues produce a number of signaling 
molecules including BMPs, shh and FGF8 within and adjacent to the 
p r o s e n ~ e p h a l o n ' ~ ~ ~ ' ~ ~ ~ ~ ~ .  The expression of most BMPs is restricted to the dorsal 
prosencephalon, while shh expression is largely ventrally restricted and FGF8 
expression is primarily in the rostrum of the A I V R ' ~ ~ ~ ' ~ ~ .  Within the forebrain 
BMPs repress FGF expression, and shh maintains FGF e x p r e s ~ i o n ~ ~ ~ ~ ~ ~ ~ .  The 
positional cue generated as a result of the combinatorial actions of these factors 
regulates the expression of regional specific transcription factors, which have 
direct effects on proliferation, survival, specification and morphogenesis. 
Neuronal differentiation is promoted by both platelet-derived growth factor 
(PDGF) and by NT-3. The cytokines leukemia inhibitory factor (LIF) and ciliary 
neurotrophic factor (CNTF) are potent inducers of astrocyte production, and 
thyroid hormone induces oligodendrocyte d i f f e ren t ia t i~n '~~ - l~~ .  0,ther factors, 
such as BlWPs can enhance both neuronal and astrocyte differentiation, 
depending on the age of the stimulated cortical progenitors 180,181 
Signal Transduction of Bone Morphoqenetic Proteins 
Bone morphogenetic proteins (BMPs) are members of the TGF-P 
superfamily of secreted signaling m o ~ e c u l e s ~ ~ ~ ~ ' ~ ~  with the exception of the 
metalloprotease BMPI. There are more than 20 members known that can be 
subgrouped according to the homology in their ~ e q u e n c e l ~ * - ' ~ ~ .  BMPs are highly 
conserved across the animal kingdom having been shown to participate in 
numerous developmental events. For example, they influence gastrulation, 
osteogenesis, neurogenesis, hematopoiesis and a p ~ ~ t o s i s ' ~ ~ - ~ ~ ' .  Despite the 
numerous extracellular ligands, only three Type-l and three Type-ll receptors are 
known to mediate the s i g n a ~ s ' ~ ~ - ~ ~ ~ .  Following ligand binding to at least one Type- 
I and one Type-ll receptor, the Type-ll receptor phosphorylates the Type-l 
receptor on specific serinelthreonine residues204s205. The wide diversity of 
biological effects appear to be partly due to intracellular cofactors that participate 
in BMP signal transduction, as well as cross talk between BMPs and other 
signaling pathways. Following phosphorylation of BMPR-I the R-Smads are 
phosphorylated and released from the receptor and recruit the common mediator 
Smad (Co-Smad, Smad4) into the signaling complex that is transported into the 
nucleus and activates the transcription of specific target gene206-212. In addition to 
Smad signaling, BMPs have recently been shown to lead to the activation of p38 
through additional receptor adapter proteins TAKI/TABI~'~-~~~. Furthermore, 
there is data showing the activation of the RAS pathway and ERK kinase 
pathway due to BMP s t imu~at ion~ '~-*~~.  
Bone Morphogenetic Proteins. 
All BMPs are secreted as precursor proteins with an N-terminal 
hydrophobic stretch of about 50-100 amino acids. The pro-BNIP is proteolytically 
cleaved and the mature and active form is derived from the carboxylterminal 
r e g i ~ n ' ~ ~ ' ~ ~ ' .  A hallmark of all BMPs is the presence of a cystein knot composed 
of six cysteins followed by an additional cystein required for dimerization with a 
22-224 second monome12 . 
BMP Receptors. 
Binding of the BMP to at least one Type-l and one Type-ll receptor 
is necessary for activation of the BMP TO date three Type-l 
receptors have been identified [Alk2, Alk3 (BNIPR-la), Alk6 (BMPR-lb)] and three 
Type-ll receptors [BMPR-II, ActRll and ~ c t ~ l l ~ ] ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ' ~ ~ ~ ~ ~ ~ ~ .  Generally, the 
Type-l receptors are the high-affinity binding receptors, whereas the Type-ll 
receptors bind the BMPs alone with low affini@00s2271228. Interestingly, the Type-ll 
receptors are constitutively active serinelthreonine kinase receptors. The Type-ll 
receptor phosphorylates the Type-l receptor at a conserved GS-Box, a 
juxtamembrane domain enriched in glycines and serines 205,229 
The affinity for BMPs is dependent on specific Type-l and Type-ll 
receptors 200s201, supporting the concept that receptor affinity is important for the 
activation of specific signal transduction The diversity of 
signaling is also a consequence of differential receptor expression and 
downstream signaling molecules that contribute to the plethora of signaling 
responses. 
Recently, BMPR-la, BMPR-lb and BMPR-II have been shown to exist as 
either a preformed hetero-oligomeric complex or a homo-oligomeric complex on 
the cell surface232. Moreover, the oligomerization mode of the receptors at the 
cell surface determines the activation of downstream signaling. Should BMP bind 
to the high-affinity receptor BMPR-la or BMPR-lb and then recruit BMPR-II into a 
hetero-oligomeric complex leads to activation of p38. The other alternative is for 
BMP to bind simultaneously to the preformed hetero-oligomeric complex 
activating Smad signaling 
The Smad Family and the "Canonical" Signaling Pathway. 
There are three classes of Smad proteins: the receptor-activated 
Smads (R-Smads), the common-mediator Smads (Co-Smads) and the inhibitory 
Smads (I-Smads). Structurally, R-Smads (Smadl, Smad5 and Smad8) and the 
Co-Smad (Smad4) are similar in that they share two highly conserved regions, 
an N-terminal MHI domain (Mad Homology 1) and a C-terminal MH2 domain 
separated by a less conserved linker region. However, Smad4 does not contain 
the C-terminal SSXS phosphorylation motif present in R-Smads, and thus not 
phosphorylated by the receptor195s234. The MHI domain of the Smad4 and all R- 
Smads, except for Smad2, can bind to specific DNA sequences, whereas the 
MH2 domain mediates protein-protein interactions with Smads promoting homo- 
or hetero-oligomers and additional transcriptional co-activators or co- 
repressors 235-238. Both R-Smads and Smad4 activate transcription primarily 
through their MH2 domain239. This activity results, at least in part, from the ability 
of the MH2 domain to recruit the general transcriptional co-activators p300 and 
~ ~ ~ 2 4 0 - 2 4 4  
. Both p300 and CBP have histone acetylase activity, enabling them to 
increase transcription of target genes by loosening of the chromatin structure. 
While Smads alone can bind to specific DNA sequences, their affinity is 
considered to be too weak to serve as effective and highly specific DNA binding 
proteins in Thus, additional and numerous DNA binding partners are 
required for efficient DNA binding and transcriptional regulation of target genes. 
TAKIITABI and the "Non-Canonical" Signaling Pathway. 
Additional studies suggest that a mitogen-activated protein kinase 
(MAPK) pathway additionally mediates BMP signal transduction. These studies 
have shown that BMP signals can be transduced by TGF-P activated kinase 
(TAKA), a MAP kinase kinase kinase (MAPKKK), and TAKI binding protein 1 
( T A B I ) ~ ~ ~ ~ ~ ~ ~ .  When TAKI alone is over-expressed in Xenopus, it induces 
apoptosis and this function is significantly inhibited when a kinase dead mutant is 
used. However, co-injection of TAKI together with XIAP, which belongs to the 
family of inhibitors of apoptosis (IAP), reduces TAKI mediated apoptosis, but 
enhances ventralization of the embryo, thus mimicking BMP over-expression 
phenotypes245. TAB1 activates TAKI by directly binding to its catalytic domain, 
and over-expression of TAB1 enhances the ventralizing activity of TAKI when 
co-injected. It should be noted that, in addition to BMPs other ligands such as 
TGF-P, interleukin-I, and tumor necrosis factor (TNF)-a have been reported to 
activate TAKI in certain contexts 213p214,2469247, and that TAKI has been implicated 
in the activation of ,INK and p38 MAPK signaling pathways 215,216,247-249 
Neural p38 MAPK Signaling. 
In both neural and non-neural cells the MAP kinase cascades are 
among such evolutionarily conserved signaling pathways that strictly control cell 
function and fate 250-252 . Three MAP kinase cascades that converge on ERKs, 
JhIKs and p38 MAPKs have been extensively characterized, and each consist of 
three classes of serinelthreonine kinases, MAPK, MAPK kinase (MAPKK, also 
referred to as MEK) and MAPKK kinase (MAPKKK). MAPKKK phosphorylates 
and thereby activates MAPKK, and activated MAPKK in turn phosphorylates 
MAPK. Whereas the ERK cascade is primarily involved in ,the control of cell 
proliferation and differentiation by mitogens and growth factors, the ,INK and p38 
cascades are preferentially activated by environmental stresses such as UV 
radiation, X-rays, heat and osmotic shock, and by proinflammatory cytokines 
such as TNF-a and I L - I ~ ~ ~ .  
Recently, potential roles for JNKs and p38 MAPKs in neural apoptosis 
have received a great deal of attention. In particular mice lacking JhIKs display 
particular dysregulation of neural a p o p t o s i ~ ~ ~ ~ , ~ ~ ~ .  However, several lines of 
evidences have suggested that p38 MAPKs also play roles in neural 
a p o p t o s i ~ ~ ~ ~ - ~ ~ ~ .  However, these studies are primarily based upon the use of 
dorr~inant negative or pharmacological inhibitors (SB203580) of p38, and thus it 
remains unclear whether p38 pathway is involved in neural apoptosis in vivo. 
Indeed, attempts to address abnormalities in neural development in mice lacking 
the p38a gene have met with little success as embryonic lethality results during 
early to mid gestation from deficits in angiogenesis260-263. In this regard, analysis 
of conditional knockout mice and knockouts for other p38 isoforms will be needed 
to research a precise conclusion concerning a pro-apoptotic role of p38 MAPKs. 
In addition to the regulation of cell death and survival as stress-activated 
kinases, p38 MAPKs have been shown to possess diverse biological functions 
including cell fate specification and control of cellular function, including neural 
~ e l l s ~ ~ ~ - ~ ~ ~ .  Much of the current data concerning p38 signaling in neural cell fate 
decision as been garnered using the rat pheochromocytoma cell line PC12. 
Recent studies have suggested that in addition to ERK mediated pathways, p38 
signaling also participates in the nerve growth factor (NGF)-induced 
d i f fe rent ia t i~n~~~.  BMP2 also induces neural differentiation of PC12 cells 268,269. in 
this process, p38 MAPKs but not ERKs are activated upon BMP treatment. 
Consistent with this, SB203580 and dominant negative MKK3 or MKK6 
effectively inhibit BMP-induced differentiati~n~~'. Thus, p38 pathway may play a 
common role as a down stream target for both NGF and BMP mediated 
differentiation. Nevertheless, it has not been fully determined how the activity of 
p38 MAPK is regulated in neural differentiation, especially at the level of 
MAPKKK. 
The p38 pathway appears to activate MEF2 transcription factors in 
response to calcium influx into cerebellar granule cells, and activated MEF2 
regulates neural survival by stimulating MEF2 dependent gene transcription. 
Since MEF2 is primarily expressed in differentiating neurons but not in actively 
dividing neural progenitors it may act in newly formed neurons to support neural 
activity dependent mat~ra t ion~~ ' .  However, concerns over p38 signaling have 
suggested a pro-apoptotic role for p38 in neural ~ e l l s ~ ~ ~ - ~ ~ ~ .  Plausible 
explanations for this apparent discrepancy are that the developmental state and 
thus the physiological level of neural activity might control p38 pathway activation 
or the way in which cells respond to p38 activity might changes at neurogenesis 
progresses. 
NRAGE and the MAGE Family of Proteins. 
The human gene MAGE-A1 was identified by gene transfection approach 
involving the stimulation of cytotoxic T-lymphocytes directed against a melanoma 
cell line272. By hybridization of cosmids with a MAGE-A1 probe, 11 closely related 
genes were Together, these 12 genes form the MAGE-A cluster, 
located in the q28 region of the X chromosome274. A sequencing effort directed at 
the Xp21 region led to the identification of the MAGE-B cluster, which is 
comprised of four genes275-277. MAGE-C, a third group, comprises two genes 
located in ~ q 2 6 - ~ 7 ~ ~ ~ .  They were identified following the analysis of cDNA 
libraries enriched for tumour and testis-specific sequences by representational 
difference analysis. These MAGE-A, -B and -C genes are not expressed in 
normal tissues, except in male germ-line cells, and, for some of these genes, in 
placental279. Seven MAGE-A genes, two MAGE-B genes, and two MAGE-C 
genes are expressed in a significant proportion of tumours of various histological 
types. The activation of these genes appears to result from the demethylation of 
their promoter region280. 
Pold and colleagues281 have identified a fourth family of MAGE proteins 
termed MAGE-Dl located at Xpl I. The full length MAGE-Dl cDNA clone was 
described elsewhere282 and its exon-intron structure is completely different from 
other MAGE genes. MAGE-Dl is expressed in a variety of normal tissues and 
tumours, which are in stark contrast to the expression of other MAGE proteins278. 
A notable exception to typical MAGE expression has been necdin. Necdin, 
which is specifically expressed in differentiated neurons, was found as a retinoic 
acid-inducible neural differentiated protein in the embryonal carcinoma cell line 
~ 1 9 ~ ~ ~ .  The necdin cDNA encodes a 37Kda protein consisting of 325 amino acid 
residues, and the rrlRNA was expressed in brain, but not in non-neural tissues284. 
Further immunohistochemical studies showed that necdin is a nuclear protein 
expressed in differentiated postmitotic neurons and believed to function as an 
associated growth suppressor exclusively in postmitotic neurons that are 
differentiated in an irreversible manner 285z286. Necdin has been shown to bind 
several Rb interacting proteins. These include adenovirus EIA, the SV40 large T 
antigen, E2F1, and ~ 5 3 ~ ~ ' ~ ~ ~ ~ .  Similar to Rb, necdin binds and represses E2F1 
mediated t ran~cr ip t ion~~~.  Over-expression of necdin in proliferating cells induces 
growth arrest285. Unlike necdin, Rb is expressed in neuroepithelial stem cells and 
at reduced levels in postmitotic neurons68r289. While Rb is a key regulator of 
neural progenitor cell terminal differentiation, it may be less important in 
maintaining the differentiated state as p130 does. In contrast, necdin that is 
exclusively expressed in postmitotic neurons may have a role in the maintenance 
of neuronal differentiation. Thus, in neurons the existence of molecules such as 
necdin that are able to complement RbIpl30 function appear to be important in 
the maintenance of neuronal differentiation. However, it raises the question as 
whether other necdin-like molecules exist in which they share a greater functional 
similarity to Rb. Indeed, MAGE-Dl is 32% identical and 60% similarity over the 
N-terminus of the protein to necdin. This high degree of structural homology 
leads us to the investigation of functional similarity as well. 
In an attempt to elucidate novel ~ 7 5 ~ ~ ~  interacting proteins, Verdi and 
co~leagues'~~ employed the yeast two-hybrid system to screen a rat neural crest 
cDNA library. A ~ 7 5 ~ ~ ~  binding partner termed NRAGE was identified. BLAST 
search revealed sequence homologue to human MAGE-Dl. NRAGE was found 
to bind ~ 7 5 ~ ~ ~  in vitro and in vivo, and NRAGE associates with the plasma 
membrane when NGF is bound to ~ 7 5 ~ ~ ~ .  NRAGE blocks the physical 
association of p7!jNTR with TrkA, and, conversely, TrkA over-expression 
eliminates NRAGE-mediated NGF-dependent apoptosis. Thus, indicating that 
interactions between NRAGE and TrkA with p7sNTR are functionally and 
physically exclusive. NRAGE over-expression facilitates cell cycle arrest and 
permits NGF-dependent apoptosis within sympathetic neuron precursor cells. 
Therefore, NRAGE contributes to a ~ 7 5 ~ ~ ~ - d e p e n d e n t  cell death and suggests 
novel functions for MAGE family of proteins. 
Since ~ 7 5 ~ ~ ~  is expressed not only in neural tissues, but many non-neural 
tissues as well, a description of the developmental expression of p75 NTR- 
interacting proteins is hypothesized to reflect ~ 7 5 ~ ~ ~  receptor expression. An 
understanding of the developmental regulations of ~ 7 5 ~ ~ ~ - i n t e r a c t i n g  proteins is 
important for the fundamental knowledge of when and where these proteins exert 
a physiologically relevant effect in vivo. Indeed, recent work has characterized 
~ 7 5 ~ ~ ~  independent functions for NRAGE mediated apoptosis. NRAGE has been 
shown to facilitate an interleukin-3 withdrawal induced apoptosis through 
competitive binding to X I A P ~ ~ ~ .  Moreover, additional studies suggest that NRAGE 
associates with members homeobox transcription factors Msx2 and DIx5 and 
translocates to the nucleus 291s292 and this interaction is redistributed to the 
plasma membrane when the tyrosine receptor kinase ROR2 is present293. 
Collectively these results suggest that NRAGE may function in the BMP signaling 
cascade regulating early neural progenitor apoptosis. In support of this the 
capacity for NRAGE to promote apoptosis is significantly enhanced during active 
proliferation of neural progenitors294. Therefore, it becomes pertinent to establish 
the presence of NRAGE within the neural precursor pool during peek periods of 
early progenitor apoptosis and determine whether the established BMP mediated 
cell death in these cell is dependent on NRAGE. 
CHAPTER 2 
Expression Analysis of Novel p7sNTR Signaling Proteins that Regulate cell 
Cycle- Progression and Apoptosis. 
Abstract 
Neurotrophin Receptor-interacting MAGE (NRAGE) is the most recently 
identified ~ 7 5 ~ ~ ~  intracellular binding protein. Previously, NRAGE over- 
expression was shown to mediate cell cycle arrest and facilitate Nerve Growth 
Factor (NGF) dependent apoptosis of sympathetic neuroblasts in a p7!jNTR 
specific manner. Here we have examined the temporal and spatial expression 
patterns of NRAGE and three other ~ 7 5 ~ ~ ~ - i n t e r a c t i n g  proteins over the course 
of murine embryogenesis to determine whether their expression is consistent 
with its proposed functions. We demonstrate that IVRAGE mRNA and protein are 
expressed throughout many embryonic and adult tissues. The mRNA is 
constitutively expressed within each tissue across development. However, 
expression of NRAGE protein displays a tight temporal tissue specific regulation. 
During early CNS development, NRAGE protein is expressed throughout the 
neural tube, but by later stages of neurogenesis, NRAGE protein is restricted 
within the ventricular zone, subplate and cortical plate. Moreover, NRAGE protein 
expression is limited to proliferative neural sub-populations as we fail to detect 
NRAGE expression co-localized with matureldifferentiation associated neural 
markers. Interestingly, f"lRAGE1s expression is not restricted solely to areas of 
~ 7 5 ~ ~ ~  expression suggesting that NRAGE may mediate proliferation and/or 
apoptosis from other environmental signals in addition to NGF within the CNS. 
The distribution of NADE, NRlF and SC-1 mRNAs during murine development 
suggests that the action of these genes is in fact not limited to regions of 
expression either. Specifically, a detailed comparison of the spatial and temporal 
expression domains of NADE, NRlF and SC-1 during brain development 
revealed regions of co-expression with but also illustrates a distinct and 
discordant spatial and temporal expression. These results yield novel insights 
into the unique developmental characteristics of the ~ 7 5 ~ ~ ~ - i n t e r a c t i n g  proteins, 
thus revealing their diverse signaling potential during embryonic development. 
Specifically, our data supports previously characterized roles for NRAGE as a 
mediator of precursor apoptosis and a repressor of cell cycle progression in 
neural development. 
Introduction 
In the course of development, the generation of neurons and glia from 
neural stem cells is regulated at steps that include lineage commitment, 
progenitor proliferation, differentiation, cellular migration and programmed cell 
death (apoptosis). Apoptosis is crucial for regulating not only the normal number 
of terminally differentiated neurons and glia, but also the number of neural 
16,295 progenitors . 
In the classic neurotrophic theory, post-mitotic neurons compete for limited 
amounts of trophic factors, the neurotrophins, which mediate neural survival. 
Neurotrophins include four distinct and structurally related homodimeric 
compounds. Members of .this family include nerve growth factor (NGF), brain- 
derived neurotrophic factor (BDNF), neurotrophin-3 (IVT3) and neurotrophin-415 
( ~ ~ 4 1 5 ) ~ ~ ~ ~ ~ ~ ~ .  These molecules act on neurons by binding to distinct classes of 
membrane  receptor^^^. One class consists of p75 neurotrophin receptor 
( ~ 7 5 ~ ~ ~ 1 ,  a member of the tumour necrosis factor (TI\IF)/Fas/CD40 receptor 
superfamily that binds all four neurotrophins with relatively low affinity298p299. The 
other class consists of Trk receptor tyrosine kinases, including TrkA, B and C and 
their various isoforms. Binding of neurotrophins to Trks is specific, with NGF 
binding to TrkA, BDNF to TrkB and NT-3 binding to TrkC and to a lesser extent 
~ r k A ~ ~ ~ ' ' ~ .  Individual Trks are necessary and sufficient to confer a functional 
response to their cognate ligands in the absence of ~ 7 5 ~ ~ ~ ~ " .  However, Trk and 
are often co-expressed endogenously and in vitro data has shown that 
increases the affinity of NGF binding ~ r k A ~ "  and enhances TrkA 
autophosphorylation 100,302 
Despite the observations that Trk and ~ 7 5 ~ ~ ~  coordinate neurotrophin- 
dependent survival of neurons, evidence is mounting indicating that ~ 7 5 ~ ~ ~  can 
act independently of Trk as an inducer of cellular a p ~ ~ t o s i s ~ ~ ~ .  Ligand mediated 
~ 7 5 ~ ~ ~  dependent apoptosis has been demonstrated within several developing 
neural lineages including sensory neurons 135-136, sympathetic neuronsq3?, 
motoneurons '38-139 and within non-neural lineages such as oligodendr~cytes~~' 
and Schwann cells142. In vivo evidence also supports a role for ~ 7 5 ~ ~ ~  in 
apoptosis. Endogenous NGF binding ~ 7 5 ~ ~ ~  induces apoptosis in developing 
chick retina neurons303. Further evidence suggesting that ~ 7 5 ~ ~ ~  independently 
regulates cellular apoptosis comes from transgenic over-expression and 
knockout studies. Mice over-expressing the intracellular domain of the ~ 7 5 ~ ~ ~  
resulted in a dramatic increase in neural death in both the central and peripheral 
nervous system14' and mice lacking genes for ngf andlor p7!jNTR have reduced 
cell death in the retina and in the mantle zone of the spinal cord 143,304 
In an attempt to identify down-stream modl~lators of ~ 7 5 ~ ~ ~  signaling, 
several groups have successfully utilized the yeast two-hybrid paradigm. Two 
zinc finger proteins named Schwann Cell Factor-I (SC-1)14' and Neurotrophic 
Receptor Interacting Factor (NRIF) '~~ have been shown to interact with the 
juxtamembrane region of ~ 7 5 ~ ~ ~ .  A third protein, Neurotrophin Receptor 
Associated Cell Death Executor or N A D E ' ~ ~  associates with the intracellular 
~ 7 5 ~ ~ ~  death domain. These ~ 7 5 ~ ~ ~  interacting proteins functionally have been 
associated with either cell cycle regulation ( ~ c - 1 ) ' ~ ~  or NGF dependent 
apoptosis (NADE and NRIF) 147,148 . SC-1 over-expression in proliferating cells 
induces cell cycle arrest by a currently unknown mechanism, although it may be 
directly involved in the down regulation of c-myc expression. NRIF knockout mice 
showed reduced levels of apoptosis in the retina, and this reduction was 
quantitatively similar to that seen in ~ 7 5 ~ ~ ~  null mice. NADE also is involved in 
p75NTR-mediated apoptosis by regulating the activation of caspase-3 upon NGFI 
~ 7 5 ~ ~ ~  intera~t ionsl~~.  We have cloned and characterized an additional ~ 7 5 ~ ~ ~  
interacting protein we termed NRAGE for Neurotrophin Receptor-interacting 
MAGE homo~og '~~ .  NRAGE, previously reported as IVAGEDI, is a member of 
the MAGE gene family that have previously been shown to code for surface 
antigens expressed by tumour cells but recently have been implicated on 
regulating cell cycle progression, apoptosis and neurogenic 
disorders 1558278s2821305.306. NRAGE, like SC-1 and NRIF, associates with the 
juxtamembrane region of ~ 7 5 ~ ~ ~  and over-expression mediates both cell cycle 
arrest in proliferating cells, as well as a N G F - P ~ ~ ~ ~ ~  dependent apoptosis of 
sympathetic neuroblasts. Therefore, NRAGE and other ~75~~~- in te rac t ing  
proteins may posses multiple functions in vivo as a growth arrest protein and as 
a pro-apoptotic protein. 
Until recently, MAGE gene expression was believed to be restricted 
primarily to tumour cells with the exception of male germ cells and placental 
cells279. However, one notable exception is the MAGE family member Necdin. 
Necdin is expressed in virtually all postmitotic neurons and is believed to function 
as a differentiation associated growth  suppress^?^^^*^^. Recently a sub-branch of 
the MAGE family tree, consisting in part with MAGEDI (NRAGE), have been 
reported to be expressed in a variety of normal as well as transformed 
cells 155s278~282~305~306. Therefore, since NRAGE or MAGEDI may possess multiple 
functions during embryogenesis, a detailed account of the spatial and temporal 
regulation of NRAGE, NRIF, NADE and SC-1 expression is warranted in order to 
decipher the functional significance of NRAGE expression during development. 
Our results indicate that in general, the spatial and temporal expression of 
NADE, NRIF and SC-1 co-localized with known ~ 7 5 ~ ~ ~  expression in the 
developing nervous system. However, specific gene expression patterns exist in 
which these interacting proteins are expressed independent of ~ 7 5 ~ ~ ~  expression 
and each other. Also, outside the nervous system, NADE, NRlF and SC-1 mRNA 
expression, like that of NRAGE, was observed in a wide variety of tissues. The 
tissue distribution of these genes suggested that their actions are not solely 
limited to ~ 7 5 ~ ~ ~  expression domains and may indeed have functions in 
regulating development independent of ~ 7 5 ~ ~ ~  signaling events. 
Moreover, we report the developmental expression of NRAGE during 
murine embryogenesis. Both the mRNA and protein are widely expressed. 
NRAGE message is detectable early in embryonic development and is 
expressed in all tissues examined into adulthood. However, the expression of 
NRAGE protein is strongly temporally and spatially regulated in a tissue specific 
manner. During cortical neurogenesis, NRAGE protein expression becomes 
restricted to areas of active cellular proliferation and regions where trophic 
dependent apoptosis predorr~inantly occurs. In the peripheral nervous system, 
NRAGE protein levels fluctuate in concert with sympathetic neuroblasts exiting 
the cell cycle and undergoing trophic factor mediated cell death. However, this 
early phase of NRAGE expression is in the absence of any detectable NGF 
receptors strongly suggesting that NRAGE functions are independent of ~ 7 5 ~ ~ ~  
in mediated neuroblasts mitotic arrest or apoptosis. Taken together these results 
demonstrate that NRAGE protein expression yields a complex spatial and 
temporal regulation supporting a dual role as a growth arrest protein and a 
mediator of ~ 7 5 ~ ~ ~  regulated apoptosis. 
Materials and Methods 
Embryo and Tissue Collection. 
Time pregnant matings of CD1 mice were established at the Maine 
Medical Research Center Institute breeding facility. The observation of the 
vaginal plug was designated as embryonic day 0.5 (E0.5). Time pregnant 
Sprague-Dawley Rats were purchased from the Charles River Company 
(Montreal, QE, CANADA). 
Pregnant mice were sacrificed on consecutive days (E7-E21). The 
embryos were dissected from the uterus in RNAse free phosphate-buffered 
saline pH 7.4 (PBS), washed in PBS and fixed in 4% paraformaldehyde (PFA) in 
PBS. 10pm sections of parafin embedded tissues were generated using a 
progressive instrumentation microtome (Fisher). 
Murine tissues (ElO-adult), listed in table 1, were harvested, frozen in 
liquid nitrogen and stored at -80°C until use. Embryonic brain was obtained by 
dissecting directly caudle to the mandible and subsequently removing the skull 
and meninges. Neural tubes (somites 1-4, 5-12, 13-caudle) with somites 
removed but with adjacent sympathetic and dorsal root ganglia were maintained. 
62 Sympathetic Neuroblasts Isolations. 
Sympathetic ganglia's were dissected from embryonic Sprague Dawley 
rats from E13-El8 of gestation. The sympathetic chains were isolated from 
thoracolumbar regions and treated with a combination of lmglml elastase and 
lmglml collagenase in minimal essential medium at 3 7 ' ~  for 30 min. The cells 
were stained with the B2 antibody and positive cells were isolated using 
fluorescence activated cell sorting307. 82' sympathetic precursors were plated in 
a serum-free modification of L15N2 medium as described in detail 
elsewhere 307,308 
Northern Blotting. 
Mouse and rat poly-A enriched multiple tissue Northern blots were 
purchased from Clontech. A blot containing total RNA from normal human 
tissues was purchased from Invitrogen. Both human and mouse blots were 
probed with a 300 bp fragment of human NRAGE. This fragment was generated 
by polymerase chain reaction (PCR) over a common sequence (forward primer, 
5' TTT AGT AGT GGC ATT CTG GG 3'; reverse primer, 5' CCC AAC TGC CAA 
TGA GAT GG 3'). The fragment was cloned and sequenced to verify its 
authenticity. The rat blot was similarly probed, with a 400 base pair (bp) cDNA 
containing the 5' U-TR of rat NRAGE. Probes were radiolabeled with 3 2 ~ - d ~ ' r ~  
(Amersham) by random priming, and hybridizations were performed using the 
ExpressHyb system (Clontech) according to manufacturers recommended 
protocol. 
In situ hybridization. 
In situ hybridization of murine sections were performed according to the 
method of ~ r o v e s ~ ~ ' .  Negative sense control (5' to 3' orientation) and NRAGE- 
specific antisense (3' to 5' orientation) digoxigenin-labeled riboprobes were 
synthesized (Roche) from a linearized NRAGE subclone comprising a 400bp 
fragment of the NRAGE 5' UTR. Mouse p75NTR, NRIF, NADE and SC-1 
digoxigenin-labeled riboprobes corresponding to the published GenBank 
sequence were also generated. 
Briefly, slides were dewaxed in a series of three xylene washes, then 
hydrated in a graded ethanol series (100%, 90%, 70%, 50%), washed twice in 
RNAse free PBS and incubated for 20 minutes in 0.2 N HCI-DEPC H20. 
Subsequently, slides were washed twice in 2X SSC for 5 minutes and then 
incubated at 55OC in prehybridization buffer3'' for 120 minutes. At this point, the 
prehybridization was replaced with fresh prehybridization buffer containing 1 
pg1mL riboprobe and hybridization allowed to occur overnight at 55°C. 
Following hybridization, slides were treated with 20 pg/mL RNAse A and 
washed in a series increasing stringency for 10 minutes at 45°C as described 
e~sewhere~~'. After washing, sections were incubated at room temperature (RT) 
in TBST and 10% goat serum (blocking buffer) for 1 hour at which point the 
blocking solution was removed and fresh blocking buffer containing a 11200 
dilution of anti-digoxigenin-Alkaline phosphatase Fab fragments (Roche) applied 
overnight at 4OC. Following the incubation, slides were washed in a solution 
containing 100mM Tris-pH 9.5, 50mM MgCI2, 100mM NaCI, 0.1 % Tween-20 (AP 
Buffer). Visualization of bound probe was performed by incubating slides in AP 
buffer containing 75 mg/mL Nitro blue tetrazolium, 50 mg/mL 5-Bromo-4-Chloro- 
3-lndoyl-Phosphate (Roche) and 5mM Levamisole (Sigma) for up to four hours. 
Sections were washed extensively in PBS. NRAGE mRNA expression was 
visualized on an Olympus 1x70 microscope using bright field illumination 
(Olympus). 
lmmunohistochemistry. 
In this study, two affinity purified NRAGE specific polyclonal antibodies 
were employed. Both a-NRAGE antibodies were generated from GST fusion 
constructs encoding either the N-terminal 31-396 amino acids or amino acids 53- 
295 of rat NRAGE'~'. These antibodies were designed to avoid cross-reactivity 
with the Necdin and MAGE homology domains of NRAGE. Unless stated, all 
immunohistochemical procedures occurred at RT for 1 hour. 
Slides were dewaxed in a series of three xylene washes for 5 minutes 
each. Then hydrated in a graded ethanol series [loo%, 90%, 70% including 1% 
Sudan black B to prevent tissue autofluorescence (Sigma), 50%] and washed in 
PBS. Sections were incubated for I hour at RT in blocking buffer (10% goat 
serum in PBS) prior to the addition of NRAGE specific antibodies (11100 dilution 
in fresh blocking buffer). Sections were then thoroughly washed in PBS before 
the appropriate secondary antibodies (11200 dilution, Chemicon) were applied. 
Sections were then washed in PBS for 10 minutes and incubated for an 
additional 10 minutes in PBS containing 1 pglmL Hoechst 33258 (Sigma). 
Sections were again thoroughly washed in PBS and staining visualized on an 
Olympus 1 X70 fluorescent microscope. 
For the cellular determination of NRAGE expression, adherent cortical 
cultures were fixed in 4% paraformaldehyde in PBS (10 minutes), rinsed in PBS 
and co-labeled with the a-NRAGE polyclonal antibodies and monoclonal 
antibodies against either the neural markers, neurofilament48 (NF-68), 
neurofilament-200 (NF-200) and MAP2aIb or the glial specific marker, glial 
fibrillary acidic protein (GFAP) (Sigma). Appropriate species and isotype specific 
secondary antibodies conjugated to FlTC or Rhodarr~ine were used as secondary 
detection reagents together with Hoechst 33258 (1 pglml). 
Semi-quantitative RT-PCR. 
Total RNA was isolated with Trizol (Invitrogen) as per manufacturer's 
specifications. Total RNA was treated with DNAse 1 (78 U1p.L) (Invitrogen) to 
eliminate any potential genomic contamination and reprecipitated. cDNA was 
synthesized from 5 pg total RNA with Superscript II (Invitrogen) using an Oligo 
(dT)12-18 primer according to previously published  procedure^'^^. Jack slowly 
began thrusting and they rocked together in synchronous rhythm with the camel's 
gait. lrina dipped her tongue in and out of his mouth as she stroked and explored. 
They moaned at first in frustration at not being able to touch each other 
completely, but as they pounded together faster, they concentrated instead on 
the sensation of their physical connection. 
All PCR reactions were performed in the linear range of amplification as 
determined empirically for each cDNA sample generated. An 800 bp cDNA 
fragment was amplified using specific primers for NRAGE that lie outside the 
MAGE domain. A 300 bp p-actin fragment was also amplified as a positive 
control and used for semi-quantitative purposes. For NRAGE the forward primer 
sequence was 5'-CTG CCA ATG AGA AGG CTG ATA CTG-3' and the reverse 
primer sequence was 5'-AAG CTG ATG GTG TCT GCC TAG CTG-3'. The P- 
actin forward sequence was 5'- TGT TAC CAA CTG GGA CGA CA -3' and the 
reverse primer sequence was 5'- CTC TCA GCT GTG GTG GTG AA -3'. The 
p75 forward sequence was 5'- CAA CCA GAC CGT GTG TGA AC -3' and the 
reverse primer sequence was 5'- TGG CTA TGA GGT CTC GCT CT -3'. The 
NRlF forward sequence was 5'- GTG ATG CTA GAG ACC TTG GG -3' and the 
reverse primer sequence was 5'- CAC CAT GGC ATC GCT ACT GTC C -3'. The 
NADE forward sequence was 5'- CAT TCC CAA CAG GCA GAT G -3' and the 
reverse primer sequence was 5'- GGC ATA AGG CAG AAT TCA TC -3'. The 
SC-1 forward sequence was 5'- TGG CCA CGA AGT AGC ATT GG -3' and the 
reverse primer sequence was 5'- TTG ACC CGG TTT GCA ATG TG -3'. Primer 
sets cross an intron-exon boarder facilitating the detection of any potential 
genomic contamination in our samples. Arr~plification of cDNA was performed 
between 25-30 cycles (25 cycles for actin) [denature: 94OC, 30 seconds; anneal: 
56OC, 30 seconds; extension 72OC, 4.0 seconds] using 1/20th of the generated 
cDNA. PCR products were. separated on a 1% agarose gel and visualized with 
e'thidium bromide. Resulting amplification products were analyzed using a Kodak 
Electrophoresis Documentation and Analysis System 120 unit. The ratio of the 
net intensity of actin amplification to the net intensity of the NRAGE amplification 
product resulted in the relative NRAGE rrlRlVA expression level. 
Western Blotting. 
Western blots were prepared using adult and fetal CD1 mouse tissues 
collected from E l 0  through E21 solublized in Trizol (Invitrogen) and protein was 
obtained by exhaustive dialysis of the phenol-ethanol supernatant against 0.1% 
SDS, quantitated using the BCA assay310, and fractionated by 8% SDS PAGE 
under reducing conditions. After semi-dry transfer onto Immobilon-P (IWillipore), 
membranes were probed with either polyclonal rabbit a-NRAGE antibodies. Blots 
were developed using horseradish peroxidase conjugated-goat anti-rabbit IgG 
(Jackson lmmuno Research Laboratories Inc.) and a chemiluminescent reagent 
(New England Nuclear), and exposed to Fujifilm. 
Mouse Brain Cortical Cultures. 
Timed pregnant mice were sacrificed at E l 3  and the embryos were 
aseptically removed and placed in Hank's balanced salt solution (HBSS) 
(Invitrogen) supplemented with 10% fetal bovine serum (FBS). Cerebral cortex 
was removed, freed of meninges, dispersed with 0.05% trypsin-EDTA and 
filtered with 70 pm nylon cell strainers (VWR). Cells were seeded (2x10~ 
cellslmL) on poly-D-lysine coated 60 mm dishes in a medium containing 38% 
Neurobasal medium, 60% DMEMlF12, 2% FBS, and 0.4 pllmL 
penicillinlstreptomycin (Invitrogen). Once adherent (within a few hours), the cells 
were allow to differentiate for 5 days in serum free media comprised of 40% 
Neurobasal medium, 60% DMEMIF12, and N2 supplements (0.6% D-glucose, 10 
mg1L insulin, 20 mglL transferrin, 61 yM putrescine-HCI, 20 nM progesterone and 
30 nM sodium se~enite)~". Cortical astrocyte cultures were generated from E l 3  
mouse brain by seeding cortical progenitors as above and differentiating the 
adherent cells in DMEM, high glucose, L-glutamine, 10% FBS and 0.4 pllmL PS 
for two weeks. 
RESULTS 
NADE, NRIF, and SC-1 mRNAs are Extensively Expressed in Adult Mouse 
Tissue. 
To investigate the tissue distribution of p75NTR, NADE, NRlF and SC-1 
mRNAs, RT-PCR analysis was performed on total RNA isolated from selected 
adult mouse tissues (Fig. 1). NADE mRNA expression was ubiquitous in all 
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Figure 1. ~75~~~- ln teract ing  Protein mRNAs are Widely Expressed in Adult 
Tissues. 
Adult mouse tissues were assessed for ~ 7 5 ~ ~ ~  and ~ 7 5 ~ ~ ~ - i n t e r a c t o r  
mRNA expression. Reverse transcription-polymerase chain reaction products 
were stained with ethidium bromide on 1% agarose gels. ~ 7 5 ~ ~ ~  mRNA 
expression was detected in most adult tissues assessed. NADE was detected in 
all tissues assessed while NRlF and SC-1 were found predominantly in ~ 7 5 ~ ~ ~  
expressive tissues. 
tissues assessed. In general, ~ 7 5 ~ ~ ~  interacting proteins were spatially and 
temporally co-expressed with p75NTR, however the correlation was not absolute. 
For example, all three ~ 7 5 ~ ~ ~  effector transcripts were expressed in the heart 
even though no ~ 7 5 ~ ~ ~  message was identified (even after-45 cycles of 
amplification). Conversely, NRlF and SC-1 transcripts were not expressed in the 
thymus, where ~ 7 5 ~ ~ ~  message levels were observed. Each of the effectors also 
showed unique tissue distributions. SC-1 message was not observed in the lung 
where NRlF and WADE mRlVAs were identified. Furthermore, NADE mRNA was 
identified in gallbladder and adrenal gland, where neither p75NTR, NRlF or SC-1 
were expressed. Collectively these results demonstrate the wide spread 
expression of ~ 7 5 ~ ~ ~ - e f f e c t o r  proteins predominantly in concurrent expression 
with p75NTR, although there were specific differences between p75NTR and ~ 7 5 ~ ~ ~  
-effectors expression patterns implicating that p7sNTR effector proteins have a 
broader and non- ~ 7 5 ~ ~ ~  based role in signaling events during development. 
NADE, NRlF and SC-1 mRNAs Display Distinct Temporal Regulation. 
Since all three p75NTR effectors1 mRNAs were expressed within the brain, 
we chose to characterize their temporal expression throughout neurogenesis. 
Semi-quantitative RT-PCR analysis was performed on total RNA isolated from 
ElO-adult mouse brain to assess changes in mRNA levels across development 
(Fig. 2). 
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Figure 2. Transcripts for ~75*~~-lnteracting Proteins Show Discrete 
Temporal Expression Patterns During Brain Development. 
Semi-quantitative RT-PCR analysis of ~ 7 5 ~ ~ ~ - i n t e r a c t o r  protein mRNAs 
during mouse brain development (n=4 performed in triplicate). Expression levels 
are equilibrated to E l 0  p-actin levels for each age and expressed as a ratio of 
the E l 0  ~ 7 5 ~ ~ ~  interactorlactin levels. A ratio of 1 reflects no change in the 
message level compared to E l 0  levels. 
All three ~ 7 5 ~ ~ ~ - e f f e c t o r  mRNA species were expressed with specific temporal 
trends reflecting changes in mRNA levels across development. Consistent with 
published reports, ~ 7 5 ~ ~ ~  mRNA levels increase as neurogenesis progresses 
and starts to decline concurrent with the peak time of programmed cell death at 
E18, before leveling off to adult levels by birth (Buck et al., 1987). Whereas, 
NRlF gene expression gradually decreased as development progressed, SC-I 
message levels increased 5-fold over the same developmental window and 
NADE mRNA levels remained invariant across development. 
To localize ~ 7 5 ~ ~ ~  interacting protein gene expression to specific cellular 
regions within the brain, in situ hybridization was done on mouse serial sections 
of the developing brain (E7.5-PI). Sense riboprobes were used as controls with 
no staining detected (Fig. 3F, L, R). At E7.5, NADE and NRlF mRNA was 
detected in the egg cylinder, amnion, chorion, syncytiotrophoblast and uterine 
tissue (data not shown). Whereas, SC-1 mRNA was detected only in the embryo 
and syncytiotrophoblast at E7.5 (data not shown). By E l  I ,  the single proliferative 
neuroepithelial layer of the forebrain, midbrain and hindbrain all showed NADE, 
NRIF and SC-1 mRNA expression (Fig. 3A, G, M). Similar results were found for 
p75NTR distribution at this age (Fig. 3s). In the mouse, expansion of the cortex 
begins at approximately E l 3  with generation of the subplate. By E l 5  distinct 
cortical laminae include the marginal zone, cortical plate, subplate, intermediate 
zone, subventricular and ventricular zone. The cortical plate and subplate zones 
are transient structures with p7CiNTR expression specific to the subp~a te~ ' * -~ '~ .  In 
the E l 5  mouse, NADE, NRlF and SC-1 were identified most prominently in the 
subplate regions of the cortex (data not shown). Moreover, expression was 
observed in the subplate and cortical plate laminae from E l 6  through P I  for 
NADE, NRlF and SC-1 (Fig. 3B, C, H, I, N, 0). ~ 7 5 ~ ~ ~  mRNA was identified 
within the cortical plate and subplate zone during mid-neurogenesis (Fig. 3T). 
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Figure 3. NADE, NRIF and SC-1 Expression Coincided with p75NTR 
Expression Areas in the Developing Cortex and Neural Tube. 
Shown are in situ hybridizations for NADE, NRIF, SC-1 and ~ 7 5 ~ ~ ~  mRNA 
using serial sections of mouse embryonic tissue. Black staining and arrows 
denote positive gene expression. Panels (A, G ,  M, S): E l  1 cortex, (B, H, N, T): 
16 cortex, (C, I, 0, U): P I  cortex, (D, J, P, V): E l 5  thoracic spinal cord, (E, K, Q, 
W): E l 4  DRGs, (F, L, R) E l 5  control cortex. LEGEND: CP: cortical plate, MT: 
mantle zone, SP: subplate, VZ: ventricular zone. Scale bar for (A, F, G ,  L, M, Q- 
S) = 100 pm. Scale bar for (B-E, H-K, N-P, T-V) = 100 p.m. 
However, unlike NADE, NRlF and SC-1 by late neurogenesis receptor 
expression was predominantly restricted to the subplate cells (Fig. 3U). 
The neuroepithelial wall of the diencephalon, mesencephalon and 
mylenecephalon are formed from proliferative cells of the ventricular zone that 
migrate out into the subventricular region. NADE, NRlF and SC-1 mRNA were 
identified within the developing subventricular zones (data not shown). 
Since ~ 7 5 ~ ~ ~  is highly expressed in the neural tube, surrounding dorsal 
root ganglia and sympathetic ganglia, we assessed gene expression within these 
regions. NADE, NRlF and SC-1 were all expressed in the mantle zone of the 
developing spinal cord (Fig. 3D, J, P), as was ~ 7 5 ~ ~ ~  (Fig. 3V). Also, gene 
expression of all three ~ 7 5 ~ ~ ~ - i n t e r a c t o r s  was present in the dorsal root and 
sympathetic ganglia (Fig. 3E, K, Q, W). 
Overall, NRlF mRNA expression phenocopies the mRNA expression of 
p75NTR, supporting its role as a bona fide ~ 7 5 ~ ~ ~  effector protein. Likewise, 
NADE mRNA was spatially expressed in a similar manner to ~ 7 5 ~ ~ ~ .  The mRNA 
expression of SC-1 coincides both spatially and temporally with that of ~ 7 5 ~ ~ ~  
mRNA. -The increase in Schwann cell factor-I mRNA over time may reflect its 
role in mediating the ~ 7 5 ~ ~ ~  induced growth arrest in later development, 
presumably during glial development. 
NRAGE mRNA is Widely Expressed Throughout Development. 
The ~ 7 5 ~ ~ ~  has been implicated in mediating apoptosis both in vitro and in 
vivo. The demonstration that three ~ 7 5 ~ ~ ~  interacting proteins facilitate 
neurotrophin induced apoptosis in a ~ 7 5 ~ ~ ~  dependent manner in vitro further 
lends credence to the hypothesis that ~ 7 5 ~ ~ ~  is a pro-apoptotic receptor. We 
wished to determine whether one such mediator of ~ 7 5 ~ ~ ~  signaling, NRAGE, 
was expressed in temporal and spatial accordance to mediate such a function. 
To determine NRAGE gene expression across development, a mouse 
developmental Northern blot was probed for NRAGE using a 300 bp segment of 
the 5' UTR of NRAGE to avoid the MAGE homology domain, thus insuring our 
results would not be confounded with other MAGE family members. A single 
2.9kb band, representing the full length mRNA was detected at the earliest time 
point represented (E7) and at all subsequent ages examined (Fig. 4A) 
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Figure 4. NRAGE mRNA is Expressed Through Development and Identified 
in a Variety of Murine and Human Tissues. 
(A) Northern analysis of a developmental time course of NRAGE. NRAGE 
expression is detected at E7 through E17. (B) Northern analysis of adult rat 
tissue expression for NRAGE. (C) Northern analysis of adult human tissue 
expression for NRAGE. 
Examination of NRAGE mRNA expression at earlier embryonic ages by RT-PCR 
revealed expression at all ages tested (€3-E6) and in murine embryonic stem 
cells (data not shown). The presence of NRAGE gene expression at stages of 
development prior to the onset of neurogenesis or germ layer specification 
indicates a possible role for NRAGE other than mediating ~ 7 5 ~ ~ ~  Ineurotrophin- 
induced apoptosis. 
In general, MAGE family members are expressed only in tumour cells with 
the one major exception being the neuron specific MAGE member Necdin and 
the recently described M A G E D ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ , ~ ~ ~ .  We then addressed whether 
NRAGE, like Necdin, was predominately expressed in the nervous system or 
was more similar to the ubiquitous expression of M A G E D I ~ ~ ~ .  Probing of an adult 
rat tissue and human tissue Northern blot using the NRAGE specific probe, 
revealed that unlike Necdin and most other MAGE genes, NRAGE mRNA 
expression was detected in most tissues. An expression profile that was more 
similar to MAGED~~'  (Fig. 4B, C). In the rat, the highest levels of expression were 
detected in the brain and liver with lower levels found in the remaining tissues 
examined. NRAGE expression pattern in human tissues was also wide spread. 
NRAGE mRNA was once again most prevalent in the brain, but in contrast to the 
tissue distribution of NRAGE mRNA in the adult rat, high levels of transcripts 
were also expressed in the lung and kidney with little expression in the liver. 
Moreover, NRAGE was detected in both skeletal muscle and spleen in adult 
human tissues, two tissues in rat where the levels of NRAGE mRNA were just 
above the threshold of detection. These differences in expression patterns and 
levels may reflect either differing physiological functions or tissue regulation of 
NRAGE between species. The significance of the expansive tissue distribution 
demonstrates the unique and atypical expression pattern of MAGEDI subfamily 
members. The diverse nature of NRAGE's tissues distribution indicates potential 
physiological relevance throughout development and into adulthood and may not 
be limited to signaling events transduced through the ~ 7 5 ~ ~ ~ .  
The pleiotropic nature of NRAGE's physiological functions was 
hypothesized to be demonstrated through its gene expression distribution. Since, 
the highest levels of NRAGE expression were detected in rat and human brain, 
we asked whether this reflected a generally higher expression level of NRAGE 
mRNA throughout the entire brain or whether a subset of specific brain regions 
express varying amounts of transcripts. In addition, because each specific brain 
region develops at different time points during gestation, we were interested 
whether individual structures express NRAGE mRNA at varying levels based on 
their respective stages of development. To this end, we sectioned mouse 
embryos from E7 through adulthood and performed in situ hybridization using an 
NRAGE and ~ 7 5 ~ ~ ~  specific riboprobe. We employed riboprobes to increase our 
sensitivity and AIRAGE specificity. Negative control (sense) riboprobes revealed 
no staining (Fig. 5F, L, P). 
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Figure 5. NRAGE is Expressed in Early Neural Progenitors and 
Differentiating Neuroblasts. 
Mouse NRAGE and ~ 7 5 ~ ~ ~  mRNA expression from E l l  through Adult 
detected by serial section in situ hybridization. (A, G) NRAGE expression in the 
neuroepithelium of the E l  I cortex and the mantle zone of the spinal cord. (B, H) 
NRAGE mRNA in the E l 5  cortex detected in the ventricular zone and subplate 
and the mantle zone of the spinal cord. (C, I) Expression of NRAGE in the E l 6  
cortex was detected in the ventricular zone, subplate, and cortical plate. (D) 
NRAGE expression in the ventricular, cortical and subplate zones in the P I  
cortex. (E) Transcripts are present in the dentate gyrus, CAI ,  CA3 regions of the 
adult hippocampus (K) Within the adult cortex NRAGE mRNA is observed in 
layers I-VI. (M) ~ 7 5 ~ ~ ~  was detected in the subventricular zone of the E l  I cortex. 
(N) ~ 7 5 ~ ~ ~  was specifically localized to the mantle of the spinal cord at E15. (0) 
Within the P I  cortex, ~ 7 5 ~ ~ ~  was detected in the subplate zone. (F, L, P) No 
signal was detected in IVRAGE and ~ 7 5 ~ ~ ~  control cortex. LEGEND: CAI,  CA3: 
tracks of the hippocampus, CP: cortical plate, DG: dentate gyrus, MT: mantle 
zone, SP: subplate, SBZ: subventricular zone, VZ: ventricular zone. Scale bars: 
(A-E, G-K, M, N) 100 pm: (0, K) 50 pm: (F, L, P) 200 pm. 
Moreover, no background or signal was detected when slides were pre-treated 
with RNAse A and antisense probes utilized (data not shown). 
Consistent with our Northern analysis, the E7 egg cylinder was found to 
express NRAGE (data not shown). However, the invading syncytiotrophoblast, 
the outer syncytial layer of the trophoblast that covers each chorionic villus of the 
placenta, and surrounding uterine tissue also expressed NRAGE. The presence 
of NRAGE in the syncytiotrophoblast is consistent with previous studies having 
identified MAGE gene expression in placental tissue279. From E8 through E l l  
NRAGE mRNA was identified in all regions of the developing neural tube (Fig. 
5A). There was no apparent restriction of NRAGE expression to any particular 
brain segment and within each region, high levels of expression were observed 
throughout the neuroepithelium. Within the spinal cord, NRAGE was observed 
within the mantle zone (Fig. 5G). Similarly, ~ 7 5 ~ ~ ~  gene expression during early 
neural development paralleled that of NRAGE. ~ 7 5 ~ ~ ~  message was detected in 
the subventricular zone (Fig. 5M) and within the mantle zone of the spinal cord 
(data not shown). 
This pattern of NRAGE tissue expression was observed until 
approximately E l 4  at which point a change in spatial distribution of message was 
observed. By E15, a prominent band of NRAGE gene expression was detected 
within the subplate and ventricular zone (Fig. 5B). The mantle zone of the spinal 
cord continued to express NRAGE (Fig. 5H) as well as (Fig. 5N). This 
segregation was complete by €16 where distinct bands of NRAGE mRNA 
expression are well defined within the ventricular, subplate and cortical plate 
zones (Fig. 5C, I). These distinct cortical regions, cortical plate, subplate and 
ventricular zone continued to express NRAGE mRNA into postnatal life (Fig. 5D, 
J), whereas ~ 7 5 ~ ~ ~  was predominantly restricted to the subplate zone (Fig. 50)  
at this and subsequent ages. 
The adult brain was also found to express NRAGE. Within the cortex, 
NRAGE positive cells can be identified throughout layers I-VI (Fig. 5K). The 
dentate gyrus, CAI and CA3 regions of the hippocampus are also major sources 
of NRAGE mRNA in the adult brain (Fig. 5E). NRAGE mRNA was detected in 
numerous brain structures including, but not limited to; the neocortex, striatum, 
pallidum, hippocampus, thalamus, hypothalamus, tegmentum, tectum, 
cerebellum, pons, medulla and the spinal cord. NRAGE was also present in 
neural structures such as the developing pituitary or Rathke's pouch, the optic 
and olfactory neuroepithelium, dorsal root ganglia (DRG), superior cervical 
ganglia and the sympathetic chain. 
NRAGE Protein Undergoes Spatial Regulation. 
NRAGE mRNA undergoes a gradual spatial restriction as development 
progresses. We asked whether the protein follows the unique characteristics of 
the mRNA. To this end, we performed immunohistochemistry on serial mouse 
embryonic sections from E7 through adulthood. We utilized two distinct affinity 
purified NRAGE polyclonal antibodies: one generated to the peptide residues 
(53-295) of rat NRAGE and a second generated against peptides (31-396). The 
antibodies cross-react with rat, mouse and human protein isoforms (data not 
shown). There was no difference in the overall staining pattern using the two 
distinct antibody species. The protein expression of NRAGE revealed a similar 
distribution pattern to the mRNA. NRAGE protein was observable within the E7 
egg cylinder and in the uterine tissue (data not shown). At E l0  through E l3  
NRAGE, immunoreactive cells can be observed in the proliferative neural tube 
(Fig. 6A, B). 
Figure 6. NRAGE Protein Distribution Recapitulates the mRNA Expression. 
Mouse NRAGE protein expression from E l 0  through E l 3  detected by 
serial section immunohistochemistry. Panels A to F are embryos probed with a- 
NRAGE antibody. Panels G represents a control slide probed with pre- 
immunserium. LEGEND: DRG: Dorsal root ganglia: MT: mantle zone, VZ: 
ventricular zone. Scale bars: (A) 200 pm: (M-0) 100 pm. 
Like the mRNA, the mantle zone of the spinal cord also expressed NRAGE 
protein (Fig. 6D). In addition to the CNS, neurotrophin sensitive populations in 
peripheral nervous namely the DRG and sympathetic ganglia also express 
NRAGE (Fig. 6 Dl F). 
Complementary to the compartmentalization of NRAGE mRNA in the 
neural tube, the protein also became restricted within distinct bands in the 
cortical, subplate and ventricular zones at E l5  (Fig. 6E). Furthermore, NRAGE 
continued to be expressed within the mantle zone of the spinal cord (data not 
shown). Like the mRNA, NRAGE protein was observed in various subpopulations 
of cells including the neocortex, striaturn, pallidum, hippocampus, thalamus, 
hypothalamus, tegmentum, tectum, cerebellum, pons, medulla and the spinal 
cord. hIRAGE positive cells within the cortical and subplate zones may represent 
migratory neuroblasts that have recently moved from the ventricular zone. 
Therefore, NRAGE protein is present through the entire neuroepithelial wall 
within each brain region during early neural development. However, by late 
development cells within the proliferative ventricular zone and the transient 
cortical and subplate zones express NRAGE protein. 
In general, cells within the ventricular zone during early neurogenesis are 
neural precursor cells. These cells migrate out as development progresses to 
form the transient subplate and cortical plate zones. These rudimentary 
structures act as building blocks to form the cortical laminae in the adult. The 
localization of NRAGE to these layers prompted an investigation as to the cellular 
specificity of IVRAGE expression. lmmunohistochemistry was performed on 
developing cortical neural and glial cultures generated from E l 3  embryos to co- 
localize NRAGE protein expression with either the expression of the early neural 
specific marker neurofilament-68 ( ~ ~ - 6 8 ) ~ ' ~ ~ ~ " ~  or the glial specific marker glial 
fibrillary acidic protein (GFAP). NRAGE expression was found in both the neural 
and glial sub-populations. (Fig. 7A, B, Dl E). 
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Figure 7, NR4GE Protein i s  Identified in Cultured Neuroblasts and not in 
Post-mitotic Neurons. 
lmmunocytochemistry for NRAGE in cortical cell cultures. (A) NF-68 was 
used as a marker for early neural precursor development. (B) GFAP was used as 
a marker for astrocytes. (C) MAP2alb was used as a marker for maturing 
neurons. (D, E, F) cell stained for NRAGE. (G)  Note: Early neural precursor cells 
are NRAGE positive, whereas maturing postmitotic neurons fail to co-localize 
NRAGE. Scale bar: (A-G) 100 pm 
However, NRAGE protein did not co-localize with more mature neural markers 
such as M A P ~ ~ I ~ ~ "  (Fig. 7C, F, G) suggesting that post-mitotic or maturing 
neurons attenuate or turn off the expression of NRAGE protein. Interestingly, 
within a subset of MAP2alb positive neurons NRAGE was found to co-localize to 
nuclear compartments that displayed pyknotic nuclei characteristic of cells 
undergoing apoptosis (Fig. 8A). 
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Figure 8. NRAGE Redistributes to  Nuclear and Perinuclear Compartments. 
(A, B) Cortical neural progenitors were cultured in vitro for four days in 
differentiation media and triple stained wi,th the postmitotic neuron marker 
MAP2alb or the multipotential neural progenitor marker nestin (cyan), NRAGE 
(green) and DNA (red). NRAGE positive piknotic nuclei can be observed in 
MAP2alb expressing neurons (white arrows), where as hlRAGE is primarily 
cytoplasmic in nestin positive neural progenitors, which display low levels of DNA 
condensation (white arrows). (C-E) GFP or (F-H) NRAGE-GFP was transiently 
over-expressed in PI9 cells and subcellular distribution was monitored over a 
period of 72 hours. Over the 72-hour period GFP can be observed in both the 
cytoplasmic and nuclear compartments. NRAGE ini,tially occupies the cytoplasm 
(nuclear condensation begins) and redistributes to the membrane and 
perinuclear regions after 48 hours (nuclear fragmentation begins) with almost 
complete co-localization to 'the nucleus by 72 hours (complete nuclear 
fragmentation) Scale bar: (A-H) 50 pm 
Moreover, NRAGE expression within multipotential neural progenitors was 
primarily identified within the cytoplasm with little nuclear condensation observed 
(Fig. 8B). To further, assess NRAGE subcellular redistribution we transiently 
transfected N RAGE-G FP or GFP into P I  9 cells and observed fluorescence 
localization over a 72-hour period. GFP was found to occupy both cytoplasmic 
and nuclear compartments with no observable nuclear condensation over the 72- 
hour period (Fig. 8C-E). However, within the first 24 hours NRAGE-GFP 
expressing cells exhibited nuclear condensation with NRAGE expression 
displaying a punctuate cytoplasmic distribution (Fig. 8F). By 48 hours NRAGE 
was found primarily adjacent to the plasma membrane and a perinuclear 
compartment with nuclear fragmentation beginning (Fig. 8G). At 72 hours 
NRAGE localized to the fragmented nucleus (Fig. 8H). Therefore, these results 
suggest that LIRAGE protein is not expressed within neural populations 
undergoing active neurotrophin competitive programmed cell death, but within 
neural progenitors undergoing terminal differentiation. Further research is 
required to assess IVRAGE protein in more mature astrocytic or oligodendrocytes 
cultures. 
Collectively, these data demonstrate that during embryonic neurogenesis 
in the CNS NRAGE spatial distribution is regulated at both the mRNA and 
consequently at the protein level. NRAGE protein is expressed in all brain 
regions. Within the cortex, NRAGE is specifically localized to the cortical, 
subplate and ventricular zones. In the remainder of the brain, NRAGE is 
expressed within both the ventricular and subventricular zones and is restricted 
to neural precursors and immature neural populations. 
N M G E  Protein is Temporally Regulated Throughout Development. 
NRAGE potentially has multifaceted functions and thus a description of 
expression across development is expected to reflect endogenous physiological 
activities, The spatial distribution data supports the bipatential role of NRAGE 
during development. Therefore, a similar mechanism regulating the temporal 
distribution of NRAGE is expected to reflect its diverse developmental regulation. 
We therefore sought to characterize NRAGE mRNA and protein expression 
patterns across development. Utilizing semiquantitative RT-PCR in conjunction 
with Western blotting we analyzed the temporal expression of NRAGE message 
and protein in most major embryonic and adult mouse tissues (for a complete list 
of tissues assayed see Table l), 
Table 1. Developmental Tissue Expression of NRAGE mRNA 
Tissue 
Heart 
Liver 
Lung 
Kidney 
Muscle 
Intestine 
Thyroid 
Thymus 
Spleen 
Blood 
E l 0  E l 2  €74 El6  E l8  €20 P I  Adult 
Brain 
Cervical N.T. 
Thoracic N.T. 
Sacral N.T. 
+ + + + + 
+ + + + + 
N.A. N.A. N.A. + + 
N.A. N.A. N.A. + t 
N.A. N.A. N.A. + + 
N.A. N.A. N.A. + + 
N.A. N.A. N.A. + + 
N.A. N.A. N.A. + + 
N.A. N.A. N.A. + + 
N.A. N.A. N.A. N.A. N.A. 
+ + + + + + + + 
+ + + + + + + + 
+ + + + + + + + 
N.A. + + + + + + + 
Legend: NRAGE positive tissue: +, NRAGE negative tissue: -, Tissue not tested: 
N.A. (not applicable) 
NRAGE mRNA was identified at all developmental ages for each tissue 
assessed with the exception of fetal and adult blood (Table 1). A common pattern 
of mRNA expression was observed regardless of the tissue assessed. This is 
demonstrated by the ratio of NRAGE message to actin message within the 
nervous system. The relative level of NRAGE mRNA was constitutively 
expressed 'throughout development (Fig. 9A, B). 
Figure 9. NRAGE Displays Tissue Specific Temporal Regulation. 
(A) Ethidium bromide stained agarose gels of reverse transcription- 
polymerase chain reaction (RT-PCR) products. First strand cDNA amplification of 
\!RAGE resulting in a -800 bp fragment or -300 bp p-actin fragment and 
Western blots of NRAGE with an approximate molecular weight of 97 KDa. Note 
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NRAGE mRNA was identified at all ages, whereas the protein is regulated in a 
tissue specific manner. (B) The graph outlines the relative quantitation of NRAGE 
mRNA across development as depicted from A. IVRAGE levels are equilibrated 
to actin levels for each age and expressed as a ratio to the E l 0  NRAGElactin 
levels, or E l 2  for the sacral neural tube. An n=4 for is represented in the graph. 
(C) semi-quantitative RT-PCR analysis of B2+ sympathetic neuroblast NRAGE 
gene expression. Graph is equilibrated in the same fashion as B with an n=4. 
Note: NRAGE mRNA and protein levels peak concomitant in the thoracolumbar 
region at approximately E14. 
For every tissues examined, only minimal modulation in mRNA message was 
observed during embryogenesis through adulthood. Intriguingly, a major 
exception to this typical NRAGE mRNA profile occurred within the developing 
thoracic neural tube. In the region that both the NGF dependent DRG and 
sympathetic ganglia reside, there was an elevation in both protein and mRNA 
message levels commencing at day E l 4  and again at E l 8  for the mRNA (Fig. 
9B). Since our segments included several cell populations, we focused 
specifically on the expression within the developing DRG and thoracolumbar 
sympathetic chain over gestation (E14-E18). To this end, DRGs and B2+ 
sympathetic ne~~roblasts were isolated and RNA and protein extracted. The level 
of NRAGE message during gestation mimicked what was observed in our 
thoracic neural tube segments except the elevation of NRAGE mRNA was 
significantly enhanced (-3 fold) (Fig. 9C). Due to the limitation in cell number, we 
were not able to quantify whether the raise in protein matched the rise in 
message, but since a rise in protein was also detected in the thoracic section 
studies we assume a significant rise in protein would follow. 
Characterization of NRAGE protein expression demonstrates a distinct 
pattern of tissue expression regulation compared to the mRNA. Unlike the 
constitutive mRNA expression, the expression of NRAGE protein is under 
stringent temporal regulation (Fig. 9A). Within the developing mouse nervous 
system, NRAGE protein appears as early as E7 (first day examined) but by P I  
unlike the rnRNA, protein levels were under the limits of detection, even after 
prolonged exposure times and increasing the concentrations of the two NRAGE 
specific antibodies used. 
Specifically, NRAGE protein levels were identified during brain 
development maximally at E9 through E l 0  and .then decreasing at E12, 
remaining low until birth when the protein is virtually undetectable. The heaviest 
staining of NRAGE protein was observed between E12-El4 in the thoracic 
region, including dorsal root and sympathetic ganglia. Expression was detected 
until E20, a key chronological landmark since trophic mediated survival begins as 
early as E l 6  and continues into postnatal life3''. The presence of NRAGE protein 
in this segment and within these neurotrophin sensitive populations supports a 
role for NRAGE in this process, consistent to the observations of Salehi and 
co~leagues'~~. In the latter tissues, NRAGE appears to migrate as a doublet, 
possibly reflecting post-translational protein modification. In the thoracic neural 
tube, the upper band of this 97K doublet is particularly prominent at E16. 
Possible phosphorylation andlor ubiquitination are currently being assessed as 
an explanation for this shift in NRAGE expression. These data indicate that 
despite constitutive levels of NRAGE message, the temporal expression of the 
NRAGE protein constitutes the greatest level of regulation. 
Discussion 
Developmental Expression of NADE, NRlF and SC-1 During 
Em bryogenesis. 
Our data demonstrate that primarily the ~75~~~- in te rac t ing  proteins, 
NADE, NRlF and SC-1 are expressed in concert with p7sNTR during 
neurodevelopment. Temporally, the expression of ~ 7 5 ~ ~ ~  with these three 
effector proteins also supports their predicted roles as mediators of mitotic arrest 
and apoptosis. What is most intriguing is the distinct expression patters displayed 
by the two effectors putatively associated with apoptosis. NRlF levels decline 
while the levels of NADE remain invariant during neurodevelopment. Since our 
PCR analysis is a population assay we cannot ascertain the total message or 
corresponding protein levels within individual cells. However, it is interesting to 
speculate that the total amount of NADE and NRlF or perhaps the ratio of these 
two proteins in conjunction with the expression of p75NTR, is what makes an 
individual neuroblast or glioblast more or less susceptible to ~ 7 5 ~ ~ ~  mediated 
apoptosis. In this way, ~ 7 5 ~ ~ ~  mediated cell death may be an early way to limit 
the number of neuroblasts or glioblasts prior to overt differentiation, Trk induction 
and the classic target derived neurotrophin mediated apoptosis seen in later 
development. However, what may be more telling regarding the roles these 
proteins play during development is that in addition to co-localization with p75NTR, 
each gene is expressed in a unique pattern independent of and each 
other. 
During development is found in the transient subplate region of the 
cortex, cholinergic neurons of the basal forebrain, nucleus basalis, striatum and 
the motor columns of the spinal cord in murine and primate species 138,313,320,321 
In addition to expression in the CNS, ~ 7 5 ~ ~ ~  is found in the peripheral 
sympathetic and sensory neurons 3209322. Within the nervous system, ~ 7 5 ~ ~ ~  has 
been shown to mediate a number of physiological and developmental events 
including; apoptosis of cholinergic neuron in the neostriatum 135z323, modulation of 
the cholinergic forebrain neuron physiology324, and promotion of apoptosis in 
seizure-induced rats within the hippocampus, piriform cortex, and entorhinal 
cortex325. Moreover, retinal and mantle zone neurons are sensitive to ~ 7 5 ~ ~ ~ -  
mediated apoptosis 143.303 . p75NTR is also required for naturally occurring cell 
death within the sympathetic and sensory g a n g ~ i a ' ~ ~ ~ ' ~ ' ~ ' ~ ~ .  The most recent 
report demonstrates that p75NTR knockout mice have severe nervous system 
defects, and unexpectedly show a requirement for p75NTR expression in vascular 
development304. Even though expression of ~ 7 5 ~ ~ ~  in any given cell population 
does not predetermine whether apoptosis will occur, it is still important to address 
the spatial and temporal relationships of ~ 7 5 ~ ~ ~  and ~ 7 5 ~ ~ ~  -interacting proteins 
in order to better understand the functions of and its interacting proteins 
during development. 
Consistent with the diverse expression pattern of p75NTR, all three 
interacting proteins examined, NADE, NRIF, and SC-1 showed a widespread 
tissue distribution. Within the brain, the localization of NADE, MRIF and SC-1 to 
the subplate and cortical plate implicates an involvement in the development of 
migratory maturing cells. The observation that ~ 7 5 ~ ~ ~  is neither expressed nor 
required for apoptosis in these regions of the cortex does not diminish previously 
characterized functions of known ~ 7 5 ~ ~ ~  interactors. NADE and NRlF expression 
coincide with the spatial arid temporal establishment of neural circuitry, 
differentiation and synaptogenesis during developmental stages where high 
levels of trophic-dependent apoptosis are occurring. 
NRlF knockout mice were previously shown to be indistinguishable from 
N TR-I- what has been observed in p75 and ngfl- mutants326. Our results support the 
widespread gene expression reported by Casademunt and colleagues326. Similar 
to NADE, NRlF demonstrates ~ 7 5 ~ ~ ~  concurrent expression in the subplate, optic 
vesicles, otic vesicles, mantle zone of the spinal cord and sympathetic and 
sensory ganglia. The strong correlation between NRlF and ~ 7 5 ~ ~ ~  expression 
lends evidence to the relevance of NRlF as a bona fide ~ 7 5 ~ ~ ~ - i n t e r a c t i n g  protein 
mediating apoptosis in vivo. Interestingly, other zinc finger proteins have also 
been shown to promote apoptosis and may work in concert with MRIF. Zacl a 
tumor suppressor gene expressed in the brain was suggested as a model protein 
whose function may mimic NRIF's function via a non-p75 mediated 
A comparison of the expression domains of NRlF and Zacl 
support this notion as NRlF and Zacl have reciprocal distribution patterns within 
the brain327. 
The zinc finger containing protein SC-1 has the greatest stringency in its 
developmental expression profile. The tissue distribution is more refined than that 
of NADE or NRIF. Within the CNS, SC-1 was identified most prominently in the 
cortical and subplate regions and also in the mantle zone of the spinal cord. 
Likewise, expression was observed in the peripheral ganglia. The level of SC-1 
mRNA increased as development progressed, with maximal levels obtained only 
in adulthood. SC-1 was originally identified and cloned in Schwann cells'49. Since 
SC-1 is expressed in both the PNS and CNS, and glial formation follows neural 
development, it is more likely than not that astrocytes andlor oligodendrocytes 
are the main expressers of SC-1. However, the precise cellular resolution of SC- 
1 expression in the brain remains to be determined. 
We have described thus far the developmental regulation of three ~ 7 5 ~ ~ ~  
interacting proteins; NADE, NRlF and SC-1. We demonstrated that each gene 
has common developmental properties associated with ~ 7 5 ~ ~ ~  expression and 
function. In addition, novel in vivo roles were assessed for the unique expression 
characteristics relevant to each gene. The most provocative and recurring feature 
described to date involving any of the ~75~~~- in te rac t ing  ge es has been the 
identification of gene expression within the cortical plate. Therefore, the diverse 
signaling potential during development for each of these three genes strongly 
suggests a complex regulatory system underlying their overt characterized 
physiological properties. 
Developmental Expression of NRAGE During Embryogenesis. 
We have analyzed the expression of NRAGE, a member of the ever- 
growing MAGE gene family, during murine embryogenesis in order to attempt to 
correlate the gene expression with potential functions during development. Both 
the mRNA and protein are widely expressed. NRAGE mRNA was identified at 
the earliest embryonic day tested (E3) and the protein was found from E7 
through adulthood, depending on the tissue assessed. The mRNA is 
constitutively expressed from embryogenesis to adulthood. However, the protein 
undergoes tissue specific structural and temporal regulation across development 
suggesting that the strongest regulation of NRAGE expression is post- 
transcriptional. In the developing nervous system, peak levels (E12) occur during 
early development when the brain and spinal cord are undergoing rapid 
proliferation and expansion. NRAGE mRlVA and protein were apparent in all 
brain regions with expression detected throughout the entire neuroepithelial wall 
during early stages of neurogenesis. During later stages of neurogenesis, 
NRAGE was specifically localized to the cortical plate, subplate plate and 
ventricular zone of the cortex. Both the ventricular and subventricular zone of the 
midbrain and hindbrain express hIRAGE and this expression is probably 
restricted to neural precursors or immature neurons since NRAGE co-localizes 
exclusively in within NF-68 positive cells. Localization of NRAGE to the 
proliferative ventricular zone is suggestive of a role in cell cycle regulation or 
early neural progenitors, whereas expression within the subplate and cortical 
plate correlates with areas where post-mitotic neurons undergo cell death 
mediated by the traditional neurotrophic hypothesis. 
NRAGE, like its closest family members MAGEDI is expressed in most 
tissues examined, supportive of a potential essential role for the cellular function 
of NRAGE. However, elucidation of cellular function has proven difficult to assess 
due to the very low levels of detectable endogenous and transfected protein 
expression in a variety of primary and cell lines, e.g. COS7, PC12, P19, U87, C6, 
MAH and 293 cells (S.K., D.G., and J.M.V. unpublished results). This narrow 
range of accumulation of NRAGE protein in these cell lines indicates stringent 
regulation for cell viability andlor normal cellular proliferation. Over-expression of 
NRAGE protein appears to be toxic to recipient cells, and the proportion of 
successfully transfected cells that express tagged NRAGE cDNAs is extremely 
low. Taken together that transfected cells also reduces proliferative levels155 it is 
possible that only cells in a particular stage of their cell cycle allow for the over- 
expression of NRAGE. These results are in agreement with previous findings 
from Casademunt and co~ logues '~~ indicating poor cellular expression of 
transfected NRIF, possibly via a cell cycle dependent mechanism. 
In the PNS NRAGE Correlates with Sensory and Sympathetic Neuron 
~ 7 5 ~ ~ ~  Mediated Apoptosis. 
For neural tube development, NRAGE is present when motoneurons of 
the floor plate are beginning to undergo trophic dependent programmed cell 
death328 and the lateral motor column shows high levels of ~ 7 5 ~ ~ ~  expression at 
this time329. NRAGE has previously been detected in m o t o n e ~ r o n s ~ ~ ~ .  However, 
the importance of ~ 7 5 ~ ~ ~  mediating apoptosis within motoneuron pools in vivo 
has been questioned since deficient mice fail to display any significant 
loss in motoneuron populations 138,322 
The neural tube dissections allowed for the collection of both the 
sympathetic and dorsal root ganglia. The presence and timing of expression of 
Trk and ~ 7 5 ~ ~ ~  in both these structures has been well documented308'37s329.330. 
Moreover, has been shown to be required for promoting apoptosis in 
these neural The timing of sensory and sympathetic 
neurotrophic dependent cell death commences at approximately E l 4  and E l 7  
r e s p e c t i v e ~ y ' ~ ~ ~ ~ ' ~ .  Unlike the CNS where NRAGE protein is diminished prior to 
the onset of neurotrophin mediated cell death, NRAGE is expressed in the DRGs 
and sympathetic ganglia prior and during the period of programmed cell death. 
The expression of NRAGE within the purified 62' population of 
sympathetic neuroblasts reveals an interesting insight into the potential function 
of NRAGE in the PNS. Both hlRAGE protein and message are expressed in 
sympathetic neuroblasts, yet ~ 7 5 ~ ~ ~  is only expressed after the onset of mitotic 
arrest'001329. This means that if NRAGE mediates the cell cycle withdrawal of 
committed neuroblasts it is through a p75 independent mechanism. 
So what if any function does NRAGE and interactions have in the 
formation of the PNS? It is possible that N R A G E - ~ ~ ~ ~ ~ ~  work to cull neurons that 
reach their targets but have failed to reach sufficient levels of Trk on their cell 
surface making apoptosis an instructed extrinsic event ( P ~ ~ ~ ~ ~ - N R A G E )  as 
apposed to a default intrinsic pathway lacking NGF stimulation. This would be a 
twist on the classical neurotrophic .theory in that neurons that do not receive 
sufficient neurotrophic support from lack of Trk-NGF die as a consequence, but 
also may be instructed to undergo apoptosis as a result of NGF- P ~ ~ ~ ~ ~ - N R A G E  
activation. 
In the CNS NRAGE Protein Expression Correlates with Timing of a p75 NTR- 
Independent Neural Precursor Apoptosis. 
During brain development NRAGE is present predominantly during the 
stages when the ventricular and subventricular region are undergoing rapid 
proliferation of neural precursor cells. Concomitant with differentiation and 
migration of neuroblasts from the ventricular region, NRAGE localizes to this 
proliferative layer. Although, the spatial distribution of NRAGE protein is largely 
independent of ~ 7 5 ~ ~ ~  receptor expression within the brain NRAGE does co- 
localize with ~ 7 5 ~ ~ ~  in the subplate region. ~ 7 5 ~ ~ ~  has been detected within the 
subplate in rat, primate and human species cerebral cortex 324,332-334 
Furthermore, p75NTR has recently been show to promote survival of subplate 
neurons in vitro in a Trk independent fashion335. In addition to the subplate, 
NTR - NRAGE co-localizes with p75 In basal forebrain cholinergic neurons located in 
the medial septum, diagonal band of Broca, nucleus basalis and 
striatum 31333339336p337. The basal forebrain has been shown to be sensitive to NGF 
induced a p o p t ~ s i s ' ~ ~ .  However, an involvement of NRAGE in mediating 
apoptosis in the striatum has yet to be determined. 
Taken together these results do not preclude the possibility that NRAGE is 
involved in a ~ 7 5 ~ ~ ~ - m e d i a t e d  neural apoptosis. However, this does not seem 
likely since NRAGE levels are significantly reduced during the timing of trophic 
dependent apoptosis. However, the significant level of NRAGE in the ventricular 
zone certainly indicates an ancillary function to that of ~ 7 5 ~ ~ ~ .  Like Necdin, 
NRAGE functions as a growth arrest protein and may function in mediating 
mitotic arrest when neuroblasts are beginning to differentiate and migrate from 
the ventricular zone. 
The fact that hIRAGE may possess roles apart from ~ 7 5 ~ ~ ~  during 
development does not exclude a pro-apoptotic function in a cell cycle dependent 
manner within the brain. Previous studies have shown that molecules acting 
during cell cycles progression are required for apoptosis. These include mitotic 
k ina~es~~ ' ,  the tumour suppressor gene p53 which is required for neural 
precursor cell a p o p t o ~ i s ~ ~ ~  and cyclin D ~ ~ ~ ~ .  There is growing support indicating 
the existence of two functionally distinct types of programmed cell death in the 
nervous system of developing mammals. This early neural cell death affects 
neural precursor cells and young neuroblasts involved in an active mitotic cycle, 
whereas trophic dependent cell death involves postmitotic neurons16. Recent 
estimates indicate that between 50-70% of cortical neuroblasts in the proliferative 
ventricular zone undergo apoptosis in murine and primate While the 
precise number of neural precursor cells undergoing apoptosis is under 
debate26,'341-343 the importance of this developmental event has been inferred 
from the studies of caspase-3, -9 and APAF-1 deficient mice. These knockout 
mice all exhibit marked ventricular zone expansion32n33r3441345. The selective 
enlargement of the ventricular zone during early neurogenesis suggests that 
caspase-3, -9 and APAF-1 functions are essential for apoptosis during early 
development of the CNS and that in the absence of normal neural precursor 
apoptosis cell development is abnormal346. Timing of neural precursor apoptosis 
within the CNS is region specific, generally cell death commences at around E10, 
reaching a peak around E14, and then decreasing postnatally to low levels seen 
in the adult. This early-programmed cell death coincides very well with both the 
spatial and temporal distribution of NRAGE. Taken together with the fact that 
NRAGE levels peak just prior to the onset of the neural precursor apoptosis and 
that concurrently the first cortical neurons are exiting the cell cycle at it 
becomes important to determine whether NRAGE may function as a molecular 
switch between cell proliferation and apoptosis for neural precursor cells in the 
developing mouse cerebral cortex. 
Other studies are also consistent with the operation of extensive 
neuroproliferative apoptosis related to the progression of the cell cycle. 
Thomaidou and colleagues26 demonstrated that the commitment to die in the 
developing ventricular zone of the cerebral cortex is integrally related to the G I  to 
S transition. A primary function in linking cell cycle and cell death is exerted by 
proteins acting as cell cycle checkpoints. A key regulator of the G I  to S transition 
is E ~ F - I ~ ~ ~  and mice lacking E2F-1 have a suppressed level of a p o p t o ~ i s ~ ~ ~ .  The 
p53 protein is another transcriptional regulator of the G I  to S transition and is 
also involved in promoting apoptosis of neural precursor cells in a caspase 
dependent manner339. Thus, it appears that cell cycle proteins are important, for 
at least some apoptotic mechanisms that result in the activation of caspases 
during early neural cell death. However, further research is required to draw 
definitive concludes pertaining to NRAGE activity during neural precursor 
apoptosis. 
NRAGE was also identified in many other non-neural tissues throughout 
development. Similarly .the ~ 7 5 ~ ~ ~  receptor is expressed in a variety of other non- 
neural tissues, both in the embryo and the adult. The gross tissue distribution of 
NRAGE is in agreement with the distribution of previously characterized 
in rats350v351. However, our result also identified non-neural regions that are not 
known to express ~ 7 5 ~ ~ ~ .  Therefore, these results can be attributed to the 
proposed diverse nature of NRAGE's endogenous function as a growth arrest 
protein and as a mediator of a ~ 7 5 ~ ~ ~ - i n d e p e n d e n t  pro-apoptotic signaling factor. 
Within the majority of tissues AIRAGE expression is correlated within 
populations of renewable cells and immature differentiated phenotypes, for 
example the testis (spermatozoa production), intestine (epithelial turnover), skin 
(dermis), spleen (lymphocyte production), liver (hepatocyte turnover), pregnant 
uterus, and olfactory bulb and neural precursor cells of the adult brain. 
The expression of NRAGE throughout early stages of embryogenesis 
suggests that this protein plays an important signaling role(s) in the development 
of the neural tube, brain and many non-neural tissues as well. The function of 
NRAGE at these early times may not be mediated through neurotrophin 
interactions, as we observed in the thoracolumbar B2+ population. In this 
population of purified sympathetic neuroblasts, hlRAGE expression correlates 
with excite from the cell cycle prior to expression of Trk or ~ 7 5 ~ ~ ~ .  However, 
under strict spatial and temporal regulation when expressed in the presence of 
p75NTR, NRAGE may mediate an NGF cell death-signaling cascade. This may be 
a novel mechanism by, which sympathetic and presumable sensory neuroblasts 
that do not express TrkA or insufficient levels of TrkA may be culled from the 
population of innervating neuroblasts. When expressed in the absence of 
under a different set of spatial, temporal and possibly structural regulations, 
NRAGE may induce cell cycle arrest potentially leading to apoptosis through a 
novel mechanism. 
CHAPTER 3 
NRAGE Regulates p38 Activation to Mediate the Transition Between BMP 
Induced Apoptosis and Differentiation of Neural Progenitors. 
Abstract 
Understanding the molecular events that govern neural progenitor lineage 
commitment, mitotic arrest and their differentiation into functional progeny are 
germane to our comprehension of neocortical development. Bone morphogenetic 
protein (BMP) farriily members play pivotal roles in regulating neural 
differentiation and apoptosis during neurogenesis through either Smad and/or 
TAKl activation. NRAGE posses the ability to function as a key component in the 
TAKl signaling cascade stimulating p38 activation leading to the induction of 
apoptosis. Loss of NRAGE function in multipotenital neural progenitors leads to 
loss of neuronal differentiation potential through perturbation of progenitor 
terminal mitosis. The capacity for NRAGE to modulate the cell cycle is well 
observed through over-expression that results in a rapid GI-S arrest with an 
aberrant S phase re-entry. These studies support a model in which NRAGE 
server as a modulator of downstream signaling events affecting the balance 
between cell cycle progression, differentiation and apoptosis. 
Introduction 
The pseudostratified neuroepithelium of the neural tube is generated from 
neural progenitor cells located within the ventricular and subventricular (VZISVZ) 
zones352. The fate of neural progenitors is defined by their microenvironment 
including effects from extra-CNS tissues'783353-363. The generation of specific 
cellular phenotypes, neurons, astrocytes, radial glia and oligodendrocytes occur 
during tightly regulated spatial and temporal windows throughout err~bryogenesis 
and early postnatal life. Regulation is complex requiring transitional changes in 
intrinsic cues and the availability of extrinsic growth, differentiation and survival 
cues. Further complicating our understanding of stem cell progression from self- 
renewing multipotential cell to differentiated progeny within the cortex, is the 
increasing recognition that programmed cell death or apoptosis is a prominent 
event regulating cell number throughout the entire pathway from stem cell to 
neural progenitor to mature differentiated phenotype 19,23,29,173.343.364-368 ~h . e 
regulation of cell numbers during all facets of neural development may be 
important for the correct temporal and spatial generation of cell phenotypes and 
consequently accurate brain morphogenesis. 
The fate of neural progenitor cells is regulated in part by bone 
morphogenetic protein (BMP), members of the transforming growth factor-p 
superfamily. BMPs signal through heterotetrameric complex formations of type I 
(BMPR-I) and type II (BMPR-II) serine-threonine kinase The 
"canonical" pathway activates Smadl, Smad5 and Smad4 proteins 229,370,371 
However, recently an alternative signaling pathway has been described in which 
the X-linked inhibitor of apoptosis protein (XIAP) functions as an adaptor protein 
bridging BMPR-la and TGF-P activated binding protein (TABI), an activator of 
the MAPKKK TGF-P activated Kinase 1 ( T A K ~ ) ~ ~ ~ * ~ ~ ~ ~ ~ ~ ~ .  TAKI activity has been 
shown to promote the activation of p3821532171373 Jun N-terminal kinases 
 INKS)^'^,^^^, and Nemo-like k i n a ~ e ~ ~ ~  a MAPK family member. 
The multiple functions of BMPs during embryogenesis and neural 
development include complex actions upon the neural  rest^^^^^^^^^^"^^ , apoptosis 
or differentiation of neurons and glia within the cortex'800'81,383-385 and dorsal 
spinal These apoptotic actions may be initiated through TAKA, which 
induces apoptosis in the neuroepithelium of Xenopus embryos and this cell death 
is inhibited by BCI-2214. Another prominent regulator of cell death is XIAP, which 
can directly bind and inhibit caspase More recently, XIAP has been 
shown to bind TABI, an activator of TAKA, and inhibit TAKA-induced 
a p o p t o s i ~ ~ ~ ~ .  
Collectively these observations suggest that BMPs regulate fundamental 
events during embryogenesis of the nervous system. The mechanism that 
governs a seemingly paradoxical switch between morphogenesis and apoptosis 
within the developing cortex remains unclear. However, recent work suggests 
that during the onset of corticogenesis in the mouse at embryonic day 13 (E13), 
high levels of BMPs (10-100 nglml) promote apoptosis and inhibit proliferation of 
neural progenitor cells of the ventricular Moreover, by the midpoint 
of neurogenesis (E16), BMPs promote neural differentiation of neural 
progenitors383. Work by McKay and colleagues384 describe a feed-forward 
mechanism whereby BMP actions are first induced through BMPR-la and then 
terminate through BMPR-lb. As cell surface levels of BMPR-lb exceed those of 
BMPR-la, BMPs cause a termination response of either cell death or cell 
dif ferent iat i~n~~~. Concurrent with the transition from BMPR-la to BMPR-lb, 
neural and glia progenitors are secreting BMPs thus directing both neurogenesis 
and gliogenesis in a concentration-dependent manner to make the critical switch 
385,388 to neurotrophin signals and related cytokines . 
NRAGE is a recently characterized Neurotrophin Receptor interacting 
MAGE homologue, identified in a yeast two-hybrid screen for proteins that 
interact with the intracellular domain of the p75 neurotrophin receptor ( ~ 7 5 ~ ~ ~ ) .  
NRAGE was shown to mediate both cell cycle withdrawal and an NGF-specific 
apoptosis in sympathetic precursor cells through p75NTR'55. The developmental 
characteristics of NRAGE revealed expression during early corticogenesis, 
specifically in neural progenitors of the ventricular zone and in differentiating 
neuroblast of the cortex, independent of ~ 7 5 ~ ~ ~  expression and concomitant with 
the spatial and temporal occurrence of BMP-mediated apopto~is~'~. This p7sNTR- 
independent expression suggests an alternative signaling cascade that may 
utilize NRAGE to regulate mitotic arrest and apoptosis of neural progenitors. 
Supporting this alternative for diverse cellular functions, NRAGE augments 
interleukin-3-withdrawal-induced apoptosis through binding endogenous X I A P ~ ~ ~  
and NRAGE is involved in UNC5-HI induced apoptosis of neural progenitors294. 
Based on the temporal and spatial appearance of NRAGE in the 
ventricular zone, an active area of cell cycle withdrawal and BMP-induced 
apoptosis, we investigated whether NRAGE was involved in these events during 
cortical neurogenesis. Using a loss-of and gain-of-function approach, NRAGE 
expression was shown to be a prerequisite to mediate apoptosis of neural 
progenitors through a BMPR-la dependent pathway. Activation of BMPRs leads 
to the formation of the XIAP-TAKI-TAB1 signaling cornplex in which IVRAGE is a 
crucial component regulating p38 activity. The level of NRAGE protein 
expression is critical in maintaining a balance between cell cycle progression and 
apoptosis. Under low BMPR stimulation, there is a low expression of NRAGE 
that facilitates the formation of a TAKI-TABI-XIAP-NRAGE complex that 
activates p38, driving a transient progression through the cell cycle by directly 
coupling growth arrest and cell cycle progression. Greater BNlPR activation leads 
to the induction of NRAGE and at these elevated levels, NRAGE binds both 
members of the SMAD and TAKI pathways triggering competitive and apposing 
cell cycle dynamics to initiate p53 activation and neural progenitor apoptosis. 
These abilities for NRAGE to regulate MAPK signaling and cell cycle progression 
are fundamentally important for neural differentiation and maintenance of cell 
number through gestation making NRAGE a key molecule during neocortical 
development independent of its role in neurotrophin signaling events. 
Material and Methods 
Cell Culture. 
P I9  embryonal carcinoma cells were maintained in growth medium 
consisting of a-MEM (Invitrogen), 7.5% heat-inactivated calf serum and 2.5% 
heat-inactivated fetal calf serum (Hyclone) at 37OC in 5% C02. For apoptosis 
assays cells seeded at a concentration of 1 X l o 5  cells/ml in bacteriological- 
grade culture dishes in growth media supplemented with 1 pM all-trans retinoic 
acid (RA) and/or 10 nglml recombinant BMP4 (R&D Systems) or without 
supplementation between 1-4 days. For neural differentiation PI9 cells were 
grown as aggregates in the presence of 1 pM RA for 4 days, trypsinized and 
transferred to fibronectin coated tissue culture dished in the absence of RA for an 
additional 4 days. 
Cortical neural progenitors were isolated from timed pregnant mice 
sacrificed at E l 3  and .the embryos were aseptically removed and placed in 
Hank's balanced salt solution (HBSS) (Invitrogen) supplemented with 10% fetal 
bovine serum (FBS). Cerebral cortex was removed, freed of meninges, dispersed 
with 0.05% trypsin-EDTA and filtered with 70 pm nylon cell strainers (VWR). 
Cells were seeded (2x10~ cellslml) as aggregates in a medium containing 38% 
Neurobasal medium, 60% DMEMlF12, 2% FBS, N2 supplemented (Invitrogen) 
and 0.4 pl/mL penicillin/streptomycin (Invitrogen). 
Over-expression and Loss of Function Studies. 
Over-expression studies were performed using mammalian expression 
vectors containing NRAGE-EGFP, NRAGE-myc, and an empty vector-EGFP and 
a dominant negative Smad5. Cells were transfected via Lipofectamine 2000 as 
per the manufactures recommended protocol (lnvitrogen). Loss of function 
studies employed the use of antisense morpholinos directed to the start sites of 
the genes of interest (see table 2 for sequences, delivery and knockdown 
efficiency) and delivered using EPEl as recommended by the manufacture (Gene 
Tools). 
Table2. Morpholino Sequences and Knockdown Efficiency 
Morpholinos incorporated a fluorescein tag to identify cells that have taken up the 
Morpholino sequence allowing purification of the population if required by 
fluorescence activated cell sorting. The specific p38 MAPK antagonist SB 
203580 was use at a concentration of 5 pM (Calbiochem). 
Over-expression of wild-type and dominant negative BMPR-la constructs 
was accomplished through the generation of retroviral particles. The 293 GPG 
retroviral packaging cell line was a generous gift from Dr. Chris Naus (LIBC). 293 
GPG cells were maintained in medium consisting of DMEM supplemented with 
10% FBS, 100 Ulml penicillin, 100 pglml streptomycin, 300 pglml G418, 200 
pglml puromycine, and 1.0 pglml tetracycline. To generate the retrovirus pSAP- 
expression vectors contain either wild-type or dominant negative BMPR-la were 
transiently transfected in our 293 GPG packaging cell line using Lipofectarr~ine 
2000. The supernatants were collected every 12-24 hours over a 4 day period. 
All culture supernatants were filtered through 0.45 pm syringe-mounted filters. 
Aliquots of 1.0 ml were storied at -80°C. Titration of retroviral supernatant was 
Morpholino 
NRAGE 
TAKA 
TAB1 
XlAP 
Standard 
Control 
Sequence 
5'-GGTTTCTGAGCCATAGCTCTCGTC-3' 
5'-AGCGCCCTTCAGCCCGGAGCCC-3' 
5'-CAGGCTCCTCCTCTGCGCCGCCATC-3' 
5'-CATCTTCTCTGGAAAATAGGACTTG-3' 
5'-CCTCTTACCTCAGTTACAATTTATA -3' 
Delivery 
Efficiency 
90% 
92% 
85% 
88% 
90% 
Knockdown 
Efficiency 
80% 
85% 
91 % 
74% 
0% 
* 
performed using serial dilutions (1110) of the supernatant, percent EGFP positive 
cells were determined using a BD FACS Calibur and taken as the ratio of viral 
volume per ml (CFUIml). Cells were transfected with appropriate titers of 
retrovirus using 1 pglml polybrene. 
lmmunoblotting and Immunoprecipitation. 
The following antibodies were used for biochemical analysis: a-NRAGE3+ 
396 (Salehi et al., 2000), a-Caspase-3 (Pharmingen), a-TAKI, a-p38, a-dp-p38, 
a-JNKlI2, a-P-Actin (Sigma), a-XIAP, a-BMPR-la, a-BMPR-lb, a-SMADI, a- 
SMAD5, a-TABI, a-GFP (Santa Cruz), a-klF~Bp65 (BD Biosciences), a- 
phosphoserine, a-N-myc, a-pSMAD1, a-pRB, a-p-pRB, a-p53, a-p21waf1, a- 
~ 2 7 ~ ' ~ '  (Upstate). For biochemical analysis whole cell extracts were prepared 
using Nonidet P-40 (NP-40) lysis buffer [ I  37 mM NaCI, 20 mM Tris (pH8.0), 0.5 
mM EDTA, 10% Glycerol, 1% NP-401 containing a protease inhibitor cocktail 
(Roche) supplemented with ImM sodium orthovanadate and 1.25 mM sodium 
fluoride. Concentration of total soluble protein was measured using BCA Protein 
Assay Kit (Pierce). Lysates were immunoprecipitated using 50 pg protein, 0.1 pI 
(vlv) pansorbin (Calbiochem), 1 pg1mL a-N-Myc or a-GFP antibody overnight at 
4OC. IPS were washed three times with lysis buffer and subjected to SDS-PAGE 
immunoblotting. For either immunoblotting experiments or IPS 50 pg cell lysate 
were subjected to 7-15% SDS-PAGE under reducing conditions. After semi-dry 
transfer onto Immobilon-P (Millipore), membranes were probed with appropriate 
primary antibody. Primary antibody detection was accomplished using an 
appropriate secondary horseradish peroxidase conjugate lgGs (Jackson lmmuno 
Research Laboratories Inc.), developed using a chemiluminescent reagent 
(Amersham), and exposed to Fujifilm between 1 and 2 minutes. 
Apoptosis and Cell Survival Assays. 
The number of viable and nonviable cells was determined by trypan blue 
exclusion. An equal volume of 0.4% trypan blue solution (Sigma) was added to 
the medium and left for 1 minute. The numbers of stained and total cells were 
then counted within 5 minutes using a hemocytometer. Graphed data represents 
averages taken from four samples, denoting one replicate, and depicted as the 
means 2 SD of four replicate experiments. 
All apoptosis and fluorescence-activated cell sorting (FACS) analyses 
used a Becton-Dickinson FACS Vantage SE cell sorter (Enterprise IIC laser 
providing simultaneous 488 nm and 350nm output, Spectra Physics Helium- 
Neon Laser Provides 633 nm output). Annexin-V labeling utilizes the early 
externalization of phosphatidylserine upon the outer leaflet of the plasma 
membrane by its capacity to bind annexin-V in a calcium dependent manner. 
Live cells were collected 24 or 48 hours post-apoptotic induction and labeled with 
annexin-V biotin and subsequently detected using streptavidin-PE secondary 
antibodies and analyzed using flow cytometry. For annexin-v assays 10 pg/mL 7- 
actinomycin D was used as a cell impermeable vital dye discriminating early 
apoptosis (annexin-V'l7-AAD') and late apoptosis or necrotic cell death (annexin- 
V'17-AAD'). Additional measures of apoptosis employed the characterization of 
mitochondria1 membrane permeability as determined by the Mitocapture assay 
kit (Calbiochem) and analyzed using flow cytometry according to manufactures 
specifications. 
Cell Cycle Analysis. 
For cell cycle analysis P I 9  cells over-expressing the genes of interest 
were synchronized in GOIGI using standard serum withdrawal. Briefly cells were 
cultured in serum free conditions for 6 hours, transfected in serum free conditions 
for an additional 6 hours upon conclusion serum containing medium was 
replaced and cells were permitted to grow for an additional 24, 48 or 72 hours. 
Live cells were collected, stained using a hypotonic DNA staining solution [ I  
mglml sodium citrate, 0.3% Triton-X100, 0.1 mglml propidium iodide, 20 pm/mL 
RNAse A]~'' and DNA content was analyzed on a Becton-Dickinson FACS 
Calibur using Modfit 2.0 software. NRAGE'~~' or cells were gated 
and DNA content was measured on FL2-area. The base line location of the 
GOIGI peak was set for the control'GFP cells and determined independently for 
each replicate. 
Immunocytochemistry. 
Adherent cultures were grown on fibronectin coated glass coverslips, after 
4 days cells were fixed in 4% paraformaldehyde in PBS (10 minutes), rinsed in 
PBS and labeled with the postmitotic neural markers MAP2a/b, the astrocyte 
specific marker glial fibrillary acidic protein (GFAP) (Sigma) and Nestin which 
labels multipotential progenitors (Pharmingen). Appropriate species and isotype 
specific secondary antibodies conjugated to Rhodamine were used together with 
the DNA binding dye Hoechst 33258 (Ipglml). Percentage of cell phenotypes 
were obtained for each replicate as the average of four frames and graphed data 
represented as the mean 2 SD of four replicates for each condition (NRAGE 
knockdown and Control Morpholino). 
Semi-quantitative RT-PCR. 
Total RNA was isolated, treated wi.th 1 unit of ~ L d s e  I at room 
temperature and re-precipitated. First strand cDNA was synthesized from 5 pg 
total RNA with Superscript I1 (Invitrogen) using an Oligo (dT)12-18 (Invitrogen) 
primer according to published procedures389. All PCR reactions were performed 
in the linear range of amplification as determined empirically using 1 pL for each 
cDNA sample generated. When ever possible primers were designed to cross an 
intron-exon boarder to distinguish cDNA amplification from any potential genomic 
contamination. Primer sequences and annealing temperatures are detailed in 
table 3. 
Table 3. RT-PCR Primer Sequences 
Gene 
Oct314 
Hesl 
Mash1 
Wnt-I 
Neuro 
D l  
MEF2A 
MEF2C 
DIx5 
Forward primer 9-3' 
ATGGCTGGACACCTGGCTTC 
AGACT 
AGAAGAGGCGAAGGGCAAG 
AA 
TCGGCACTGACTTTTGCGGC 
TGCTTT 
ACGTTGCTACTGGCACTGAC 
TCAGCATCAATGGCAACT 
AGAAATGCCGACAGCCTACA 
A 
AGCAAGAATACGATGCCATC 
CCGTCTCAGGAATCGCCAAC 
Reverse primer 3'-5' 
GCCAGGCTCCTGATCAACAG 
CATCA 
CAAAAAACCTTGGCAGCCTC 
T 
GAAGCACGATCAAAGGGGG 
ACGAA 
CCATTTGCACTATCGCACAG 
TGACTCGCTCATGATGCGA 
TCACCCATGTGTCCATCCTC 
A 
GAAGGGGTGGTGGTACGGT 
C 
CTGAAAGCTGGCTGGCTGGT 
Annealing 
Temperature 
63°C 
54°C 
56°C 
58OC 
56°C 
54°C 
56°C 
56°C 
Cycling parameters were as follows: denaturing 94OC, 30 seconds, annealing 
(primer specific see table 3), 30 seconds and extension at 72°C. Amplification 
products were separated on a 1% agarose gel and visualized with ethidium 
bromide. Gels depict representative experiments obtained from at least four 
replicates from four separate RNA pools. 
Statistics. 
All data are presented as the means 2 SD of at least four independent 
experiments. Significance was determined by Student's t-test. 
Msx2 
P-Actin 
Results 
NRAGE is Required in the BMP Mediated RA-induced Apoptosis. 
Since, NRAGE was expressed within the developing central nervous 
system in the absence of p75 NTR389 we asked whether NRAGE played a key role 
in the formation of the nervous system outside those roles mediated by 
neurotrophins. Since apoptosis is a prominent event in the regulation of cell 
number throughout the entire progression from stem cell to neural progenitor to 
mature differentiated neural cell and NRAGE has been shown in earlier 
studies to mediate apoptosis in sympathetic precursor cells, we initially were 
interested in deterrr~ining if NRAGE mediates apoptosis in the absence of 
~ 7 5 ~ ~ ~ - r n e d i a t e  neurotrophin signaling in embryonal carcinoma (P19) cells and 
ATTCGCCGCCGCCAAGACAT 
A 
TGTTACCAACTGGGACGACA 
TCTTTTCGCCTTGGCCCTTC 
G 
CTCTCAGCTGTGGTGGTGAA 
56°C 
56°C 
E l 3  cortical neural precursors as putative models for cortical progenitor 
apoptosis. Much of the detailed information regarding the effect of BMP signaling 
on neuroblast proliferation, differentiation and apoptosis has been garnered using 
these model  system^^^^,^^'"^^. P I 9  cells have previously been shown to be 
devoid to ~ 7 5 ~ ~ ~  receptor expression during the first 4 days of RA and/or BMP4 
76,395 induced apoptosis, but do up-regulate the receptor on post-mitotic neurons , 
Indeed, RT-PCR analysis demonstrates that early P I9  cells treated to undergo 
apoptosis through RA treatment fail to express ~ 7 5 ~ ~ ~  receptor (Fig. 10A). 
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Figure 10. RA Induced Apoptosis is Mediated Through BMP Signaling. 
(A) RNA was isolated from PI9 cells treated with RA over a 4-day period 
or RNA was isolated from E l  3 neural progenitors following 3 or 7 days of in vitro 
differentiation. Note PI9 cells do not express p75NTR, but post-mitotic neurons 
cultured from mouse neural progenitors are ~ 7 5 ~ ~ ~  positive. (B, C) Dose 
response curves were generated to determine effective dosages for the induction 
of apoptosis using increasing concentration of either RA or BMP4. PI9  cell 
survival was measured using trypan blue exclusion after apoptotic induction with 
10 nglml BMP4, 1 pM RA or both. Presented in (D) are the means 2 SD of four 
independent experiments demonstrating that RA enhances the number of trypan 
blue stained P I 9  cells using the BMP signaling pathway. (E, F) Presented are 
representative FACS histograms of P I  9 and E l  3 cortical neural progenitors (NP) 
treated with 10ngIml BMP4 and 1 pM RA. Also presented is a western analysis 
demonstrating the extent of NRAGE suppression using NRAGE antisense 
morpholinos relative to standard morpholino control. Note in both cortical 
progenitors and P I 9  cells, suppression of NRAGE expression (NRAGE KD) 
limits the percentage of annexin-v, apoptotic, cells. 
Retinoic acid (RA)-induced apoptosis of cortical progenitors and EC cells 
has been argued to occur via the BMP signaling pathway since BNIP4 and RA 
appear to act synergistically to potentiate the apoptotic effect396. Using two 
independent measures of cell survival, trypan blue exclusion and annexin-v 
immunoreactivity, we found that, in agreement with the previous data396, cortical 
neural progenitors (NP) and EC cell viability was greatly compromised when 
treated with a combination of RA and BMP4 than when cells were treated with 
either molecule alone (Fig. 10D). These results do not rule out the possibility that 
the actions of BMP and RA are additive, perhaps due to distinct populations of 
BMP-sensitive and RA-sensitive cells, nor does this result formally support the 
hypothesis that RA leads to a BMP induced apoptosis as suggested by 
Rodriquez-Leon and colleagues. In an attempt to demonstrate that RA actions 
were mediated by BMP, we attempted to exacerbate the effects of RA on 
developing neuroblasts by over-expressing BMPR-la and treating the resulting 
cells with RA. Cell survival decreased precipitously (52% 2 2) to a level 
comparable to that of the cells treated with RA and BMP4 (48% 2 1). In contrast 
cells in which BMP signaling was diminished by the expression of a dominant 
negative (dn) allele of BMPR-la, that expresses only the extracellular domain 
and is signaling incompetent, cell viability in the presence of RA was enhanced 
and approached the level of untreated controls (RA treated: 72% 2 2; RA + 
dnBIWPR-la: 85% 2 1 pc 0.01; Untreated: 95% 2 1). Moreover, RT-PCR analysis 
demonstrated that BMP2 and BMP4 transcripts were greatly elevated after 8 
hours of RA exposure (data not shown). These results support the hypothesis 
that RA-induced apoptosis of proliferating neuroblasts is mediated by the BNIP 
signaling pathways. 
We then asked if NRAGE had any role in mediating cell survival in either 
cell system. Cell viability was greatly enhanced in W B M P 4  treated cells that 
under-expressed NRAGE using specific antisense morpholinos (Fig. 10E,F). 
Conversely, the vast majority of P I 9  cells over-expressing NRAGE underwent 
cell death within 24 hours, even in the absence of RAlBMP4 treatment (Fig. 
10D). The addition of RAlBMP only enhanced the effect and the time course of 
apoptosis in NRAGE over-expressing cells. These data, taken together, 
demonstrate that the cell death signal, initiated by RA and BNIP is relayed by the 
BNIP signal transduction cascade and is mediated by NRAGE. 
To further confirm the link between NRAGE and RAlBMP4 mediated 
apoptosis, we examined the expression of NRAGE protein as a function of time 
after W B M P 4  treatment. NRAGE protein levels rose sharply one day after 
induction with W B M P  (Fig. 11A) and in primary E l 3  cortical progenitors (Fig. 
11 B). 
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Figure 11. NRAGE is Required for the Activation of Caspase-3 by RAIBMP. 
Lysate of P I 9  or NP cells harboring control morpholinos or NRAGE 
morpholinos treated with RA, BMP4 or both were collected daily and subjected to 
western analysis to determine the levels of MRAGE and active caspase-3 during 
apoptosis. In the absence of NRAGE expression, caspase 3 is not active and this 
correlates with enhanced cell survival. 
Strikingly, this increase correlated with an increase in the levels of activated 
Caspase-3 in both systems. The activation of Caspase-3 was abrogated in cells 
where NRAGE levels were reduced (Fig. 1 IA,B) and activation was conversely 
enhanced in NRAGE over-expressing cells. These results suggest that IVRAGE 
plays a pivotal role in mediating W B M P  induction of Caspase-3 and apoptosis. 
NRAGE lnteracts with Members of the BMP Signaling Cascade. 
MRAGE's role in the RAIBMP induced apoptosis prorrlpted us to clarify the 
function of NRAGE in the BMP signaling cascade. To this end, we performed 
immunoprecipitation experiments using myc-tagged NRAGE over-expressed in 
EC cells treated with BNIP4. Cell lysates were collected and Western analyses 
were performed using antibodies against various merrlbers of ,the BNlP signaling 
cascade. NRAGE was found to weakly associate with the BMP receptors BMPR- 
II and BMPR-la, while it showed a strong association with BMPR-lb. Since both 
BMPR-I and BMPR-II are capable of existing as a heterotetramer when 
activated, immunoprecipitation of both type-l and type-ll receptors with NRAGE 
was not unexpected (Fig. 12). 
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Figure 12. NRAGE Strongly lnteracts with XIAP, TAKA, TAB1 and BMPR-lb. 
Present is a western analysis of P I 9  cells transiently over-expressing full 
length NRAGE construct tagged with Myc and treated with BMP4 for 24 hours. 
lmmunoprecipitation of the resulting lysates using the myc tag were used to 
precipitate potential NRAGE binding proteins. The resulting blots were probed for 
various members of the BMP signaling cascade. 
The predominant mode of BMP signaling within the cell utilizes members 
of the Smad family. As a result, we also looked at NRAGE interaction with these 
proteins. Both Smadl and Smad5 were found to only weakly associate with the 
NRAGE complex. Interestingly, NRAGE was found to strongly interact with 
TAKA, TAB1 and XIAP (Fig. 12). These proteins are all members of a lesser- 
known pathway downstream of the BMP receptors. Previous reports have shown 
that TAB1 (TGF-0 activated binding protein) activates TAKI (MAPKKK TGF-P 
activated kinase I ) ,  which, in turn, promotes the activation of p38. XIAP (X-linked 
inhibitor of apoptosis) appears to be required to functionally bridge TAKI-TABI- 
p38 signaling through BMPR. Interestingly, over-expression of XIAP enhances 
TAKA-p38 signaling, but inhibits TAKI mediated apoptosis suggesting a complex 
regulatory mechanism245. NRAGE interaction with these members of the BMP 
signaling pathway is specific since there was no interaction between NRAGE and 
BMP independent TAKI binding proteins NF-kpp65 and Bcl-2 (Fig. 12, data not 
shown), suggesting that the main mode of BMP apoptotic activity is through this 
non-canonical signaling pathway of TAKI , TAB1 and XIAP. 
The interaction between NRAGE, TAKA, XIAP and TAB1 appears to be a 
functional one since NRAGE serine phosphorylation is reduced in cells where 
levels of XIAP, TAKI or TAB1 were reduced. Using immunoprecipitation followed 
by Western blot analysis with anti-phosphoserine antibodies, it was determined 
that in the presence of BMP4, serine phosphorylation of NRAGE was enhanced 
relative to that observed in unstimulated cells. If however, the experiment was 
repeated under conditions limiting XIAP, TAKI or TAB1 expression, 
phosphorylation of NRAGE was significantly reduced (Fig. 13A). 
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Figure 13. The TAKI, TAB1 and XIAP Complex Promotes NRAGE 
Phosphorylation. 
(A) BMP4 treatment enhanced the serine phosphorylation of NRAGE in a 
XIAP-, TAKI-, TABI-dependent manner. Protein lysates were generated from 
BMP4 treated P I 9  cells over-expressing NRAGE and harboring antisense 
morpholinos against TABI, TAKA, or control (see methods and table 2). 'The 
resulting lysates were immunoprecipated for NRAGE and immunoblotted for 
phosphoserine. (6) Western analysis demonstrating the effectiveness of TABI, 
TAKl and XIAP morpholinos. 
A Reduction in protein levels as a result of morpholino exposure was evident as 
early as 24 hours after treatment (Fig. 13B). These results suggest that NRAGE, 
XIAP, TAKI and TAB1 form a complex that promotes NRAGE phosphorylation 
and activation. 
NRAGE Regulates BMP-linked Apoptosis via the BMP Target, p38 MAP 
Kinase. 
Serine phosphorylation of NRAGE potentially leads to its activation, but 
the putative targets of activated NRAGE still remained to be determined. p38 
MAP Kinase is a target of the BMP signaling cascade that has been shown 
necessary for the apoptotic response in various cell types. We hypothesized that 
the effect of NRAGE on the BMP mediated apoptosis might also occur via this 
prominent downstream regulator. To demonstrate that NRAGE is required for the 
activation of p38 by BMP4, we looked at p38 phosphorylation in cells expressing 
NRAGE at normal and reduced levels. We also monitored p38 phosphorylation 
as a function of TAKI levels. This latter experiment functions as a positive 
control, since TAKI is a known upstream regulator of p38. As expected, 
reduction of TAKI expression via antisense morpholinos drastically perturbed 
activation of p38 (Fig. 14A). 
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Figure 14. NRAGE is Required for the Activation of p38 MAPK. 
(A) Western blotting was used to detect active, doubly phosphorylated p38 
in control cells and cells treated with either TAK or NRAGE morpholinos. 
Although all cells expressed similar levels of inactive p38, only control cells 
showed phosphorylation of p38. Reduced levels of AIRAGE or TAKI inhibited the 
appearance of active p38. In contrast, treatment with IVRAGE morpholinos had 
no effect on the canonical BMP pathway as indicated by the appearance of 
active SMAD-1. JNK was not activated as a result of BMP4 treatment. (B) 
NRAGE-myc was transiently over-expressed and cells were treated with or 
without BMP4, cell lysates were collected and immunoprecipitated. Note BMP4 
treatment facilitates BMPR-la complex formation, whereas in the absence of 
ligand NRAGE interacts only minimal with receptor components. (C) Endogenous 
NRAGE was immunoprecipitated following BMP4 treatment from NP cells. Only 
in the presence of BMP4 does NRAGE interact with BlWPR and its associated 
effects. 
More importantly, we found a similar reduction in p38 activation in cells in which 
TAK? expression was normal but NRAGE levels were diminished, suggesting 
that like TAKA, IVRAGE is a key upstream and perhaps direct regulator of p38 
activity (Fig. 14A). The down regulation of NRAGE expression appeared to have 
a specific effect on p38 activation, as there was no change in the activation of 
Smad-I nor was JNK activated as a result of BMP4 treatment (Fig. 14A). These 
results demonstrate that the induction of cell death by BMP is accomplished 
through hIRAGE's regulation of p38 activity. 
We made an initial observation that when NRAGE was over-expressed, 
application of BMP4 significantly enhanced the capacity for NRAGE to associate 
with members of the BNlP signaling cascade (Fig. 12). However, in the absence 
of ligand stimulation, prolonged NRAGE over-expression results in cellular 
apoptosis suggesting that accumulation of NRAGE can force activation of the 
BNlP signaling complex. However, in the absence of BMP4 NRAGE over- 
expression was found to interact only weekly with the receptor and its signaling 
components (Fig. 14B). Exogenous NRAGE over-expression exceeds the level 
of naturally occurring NRAGE within a cell and though over-expression exceeds 
physiological levels it highlights the important binding capacities for NRAGE 
under changing cellular circumstances. We therefore, wish to assess the binding 
interactions of endogenous NRAGE to the BMP signaling complex in the 
presence and absence of BMP4 treatment. Endogenous NRAGE IP from neural 
progenitors was found to associate with BMPR-la and XIAP, TAKl and TAB1 
only in the presence of BMP4 (Fig. 14C). Collectively, these results suggest that 
in the absence of an instructive apoptotic cue NRAGE remains inactive. 
However, following induction of apoptosis NRAGE functions in an instructive 
manner signaling apoptosis through BMP. As the cellular levels of NRAGE 
elevate the capacity for NRAGE to associate with the BMP signaling complex is 
enhanced leading to p38 activation and apoptosis. 
Having established a potential connection between BNlP signaling and 
NRAGE activation of p38 leading to cellular apoptosis in cortical progenitors (Fig 
IOF), we performed a series of similar experiments using neural progenitor cells 
as they succumb to the apoptotic actions of RA and BMP in a similar manner. 
We have previously shown that diminishing NRAGE expression in both cell 
systems attenuates BMP apoptotic events perhaps NRAGE activates p38 within 
proliferating primary progenitors. Indeed the addition of SB203580 to neural 
progenitor cells in the presence of RAlBMP resulted in attenuation of p38 
activation and enhanced cell survival (Fig. 15). 
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Figure 15. Neural Progenitors Require p38 MAPK to Mediate Apoptosis. 
Annexin-V labeling was used to detect neural progenitor cells undergoing 
apoptosis in control, W B M P  or W B M P  in the presence of the p38 inhibitor SB 
203580 (5pm). Presented in are the X 2 SD of four experiments demonstrating 
that inactivation of p38 rescues cells from apoptosis *p<0.01. 
To further confirm a role for NRAGE in RAIBMP mediated apoptosis, we 
induced apoptosis in P I  9 cells by over-expressing NRAGE and tested the effect 
of treatment with the specific p38 inhibitor, SB203580. Annexin-V labeling was 
used to detect cells in early phases of apoptosis (hlRAGE-GFP'Iannexin-V'l7- 
AAD-), and flow cytometry was subsequently used to quantify the number of 
living NRAGE-GFP' cells. In cultures over-expressing NRAGE after 48 hours, 
57% 2 8 of the cells were annexin-V immunoreactive, a significantly greater 
number than the 1 2 2% observed in the control cell GFP-expressing population 
(Fig. 16D). 
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Figure 16. RAIBMP4 and NRAGE Over-expression Exhibit Similar 
Functional Requirements to Mediate Apoptosis. 
(A-C) Reducing the expression of the canonical and non-canonical BMP 
signaling cascade abrogates NRAGE's ability and BMPs ability to induce 
apoptosis in PI9 cells. (D-F) When P I 9  cells expressing full-length NRAGE are 
deprived of canonical and non-canonical BMP signaling component apoptosis is 
efficiently reduced. In both paradigms annexin-V immunohistochemistry was 
measured by FACS. Presented are representative profiles of annexin-V positive 
cells in each condition with the X + SD of four separate experiments. 
On the other hand, the NRAGE over-expressing cell population treated with the 
p38 antagonist, SB203580, showed an irr~pressive rate of survival 10% 2 9 (Fig. 
16E). In addition, using the specific caspase-3 inhibitor Z-DQMD-FMK greatly 
enhanced the cell survival (1% 2 1) when NRAGE was over-expressed (Fig. 
16F). In other words, inhibition of p38 or the caspase cascade effectively 
prevented apoptosis in these N RAGE over-expressing EC cells. Interesting, the 
apoptosis induced through p38 was dependent on both TAKI and Smad5 
signaling as abrogation of either molecule significantly reduced the level of cell 
death observed (TAKI KD, 26% 2 4; Smad5 DN, 24% 2 7) (Fig. 16D). 
As a final insurance for the involvement of NRAGE in BMP mediated 
apoptosis we treated our P I 9  cells with RAlBMP4 for a period of 48 hours and 
subsequently determined the requirements for BMP signaling as an instructive 
apoptotic cue. As was found with NRAGE over-expression, both TAKI and 
Smad5 signaling are an absolute requirement for the induction of apoptosis 
(TAKI KD, 3% 2 6; Smad5 DN, 8% 2 3) (Fig. 16A). Furthermore, activation of 
p38 is also an important regulatory event, as inhibition of p38 by SB203580 was 
effective in reducing the level of cell death (24% 2 7) (Fig. 16B), as was inhibition 
of caspase-3 (0.6% 2 3) (Fig. 16C). Collectively, these studies demarcate 
NRAGE as a pivotal and necessary molecule in mediating the apoptotic effects of 
BMP in the developing central nervous system. 
NRAGE Regulates the GI-S Cell Cycle Transition. 
Recent data suggests that uncoordinated expression of cell cycle 
molecules and the consequent breach of cell cycle checkpoints could be one of 
the primary mechanisms by which neural progenitors undergo apoptotic death 
during terminal exit from the cell cycle. Evidence indicates that up-regulation of 
cyclin/cyclin dependent kinase activity at the G I  to S transition and deregulation 
of E2F transcription factors mark early stages of neuronal a p o p t o ~ i s ~ ~ .  Apoptotic 
signals promote successive phosphorylation and dysfunction of Rb family 
members, resulting in sequential E2F deregulation and expression of selective 
E2F-responsive genes. The MAPK p38 influences cells throughout all stages of 
the cell cycle (GI-M). Recent work suggests that p38 activation is vital to cell 
cycle regulation and apoptosis of neuronal and non-neuronal cells types 397-400 
Initiation of apoptosis was found to inactivate Rb by direct utilization of p38 in a 
cyclin independent manner resulting in unscheduled re-entry into S phase 401,402 
Since NRAGE can positively regulate p38 activity and has previously been 
shown to promote growth arrest, we assessed NRAGE's capacity to regulate 
transitions through the cell cycle. Cells over-expressing NRAGE-GFP 
( N R A G E ' ~ ~ ~ )  were analyzed for DNA content by flow cytometry at 24, 48 and 72 
post-transfection. After 24 hours NRAGE'~~' cells exhibited an enhanced 
accumulation in G2-M (44 2 3%)" relative to P I 9  cells transfected with GFP 
(control+GFP) (35 2 2%; t=7.2, p> 0.04) (Fig. 17A,B). 
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Figure 17. NRAGE Facilitates both Growth Arrest and Progression Through 
S Phase. 
(A,B) NRAGE-GFP was over-expressed, cells were collected 24, 48, and 
72 hours post-transfection and their cell cycle profile was analyzed using flow 
cytometry. After 24 hours NRAGE was driving progression through the S phase 
with cells accumulating at the G2-IV1 transition. However, by 48-72 hours NRAGE 
was facilitating a potent GI-S arrest. (C)  Disruption of p38 signaling facilitates a 
rapid G1 arrest in the presence of BMP4. (D, E) Treatment with either SB203580 
or BMP4 along does not significantly affect the cell cycle (F) Over-expression of 
both NRAGE and dominant negative Smad5 results in cells accumulating in the 
G2 phase. (G) Whereas, over-expression of DN Smad5 along does not 
significant affect the cell cycle. Collectively, these results demonstrate the 
capacity to functional separate NRAGE mediated cell cycle events depending on 
the either p38 or Smad signaling. 
By 48 hours the majority (55 2 1%) of NRAGE'~~' cells were positioned at the 
GI-S transition compared to just 43 2 2% (t=9.6, p>0.02) for control cells. The 
percentage of cells at GI-S after 72 hours was further enhanced (64 5 4%) 
compared to GFP controls (39 2 4%; t=12.3, p>0.01). These results coincide with 
previous reports suggesting NRAGE acts as a growth arrest protein (Salehi et al., 
2000). 
However, the unique bi-functional growth arrest observed within the first 24 
hours provides a provocative insight into the function of NRAGE. We have 
established that NRAGE is a critical component of the XIAP-TAK1-TAB1 
signaling cascade leading to the activation of p38. Taken with the fact that Smad 
signaling is a fundamental requirement for the mitotic arrest of neural progenitors 
through suppressing c-myc promoter activity by dissociating p300 from E2Fs 
providing accumulation of p2 1 p2i'kip1403-405 . We hypothesized that in the 
absence of p38 Smad signaling would dominate providing an immediate G I  
arrest. In support of this we found that NRAGE over-expressing cells treated with 
the p38 antagonist SB 203580 displayed a subtle G I  growth arrest (data not 
shown). However, with the addition of exogenously added BMP4 N R A G E ' ~ ~ ~ S B  
203580 treated cells rapidly exited the cell cycle displaying a prominent G I  
arrest, which is maintained over the 72 hour period (Fig. 17C). Furthermore, 
through the use of a dominant negative Smad5, NRAGE over-expressing cells 
underwent a dramatic and maintained G2 arrest (Fig. 17F), a direct result of 
unfettered p38 activity. These findings demonstrate the capability to disassociate 
specific aspects of NRAGE mediated cell cycle control revealing an antagonistic 
bi-potential function of BlblP signaling. This novel cell cycle control provides an 
attractive model where by altering levels of BMP stimulation a neural progenitor 
receives, a dynamic interplay between growth arrest and cell cycle progression is 
created. 
NRAGE Promotes a p53 Dependent Apoptosis. 
The observation that NRAGE mediated apoptosis requires both Smad and 
TAKl signaling which possess opposing cell cycle properties suggest that the 
induction of apoptosis is dependent on perturbation of the cell cycle. Cell cycle 
and apoptosis share common participants such as Rb, E2F and ~ 5 3 ~ ' .  This 
aberrant S phase reentry stimulated by NRAGE may be the underling cause of 
the pro-apoptotic action of NRAGE. Taken with the fact that there is an intimate 
link between cell cycle and apoptosis most often leading to induction of p53 when 
control is lost we wished to address the contributions of p53 to an RAIBNIP and 
NRAGE mediated apoptosis. EC control cells or p53 knockdown cells were 
treated to undergo apoptosis using our standard RAlBMP technique, following a 
48 hour treatment window cells were collected and stained for annexin-V and 
subsequently analyzed using FACS. Abrogation of p53 was effective in 
preserving cell viability, likewise, NRAGE mediated apoptosis was found to 
require p53 (Fig. 18A). 
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Figure 18. NRAGE Mediated Apoptosis is p53 Dependent. 
(A) p53 knockdown or control morpholinos were introduced into P19 cells, 
which were treated with RAIBMP4 or transiently transfected with NRAGE-GFP, 
and the percentage apoptosis was determined using annexin-v binding. Both 
RAIBIVIP4 and IVRAGE-GFP induced apoptosis require p53 as a necessary 
component for cell death signaling. (B) NRAGE'~~' cells were purified using 
FACS 24, 48 and 72 post-transfection. Cell lysates were collected and subjected 
the standard Western blotting techniques. NRAGE initially triggers activation of 
p38. However, p38 is gradually inactivated concurrent with the activation of Rb 
and p53. A direct consequence of activation Rb and p53 is accumulation of 
p21 and ~ 2 7 ~ ' ~ ' .  
To further elucidate changes in cell cycle machinery, cell lysates were collected 
from FACS purified NRAGE'~~' and control'GFP cells after 24, 48 and 72 hour 
post-transfection and then subjected to standard Western analysis. During the 
initial 48 hours activated p38 accumulated, consistent with the G2-M arrest, 
however between 48 and 72 hours active p38 was rapidly turned off, consistent 
with the G I  arrest (Fig. 18B). The growth arrest observed after 48 hours of 
NRAGE over-expression coincides with the inactivation of p38 and the losses off 
the inactive hyperphosphorylated form of Rb. The activation of Rb may contribute 
to the accumulation of the cdk inhibitors p2lWaf1 and ~ 2 7 ~ ' ~ '  with a sharp elevation 
in the phosphorylated state by 72 hours. These results are consistent with 
NRAGE'~~' induced GI-S arrest after 72 hours. In addition, p53 levels 
accumulate as time progressed; supporting the p53 dependence on NRAGE +GFP 
mediated apoptos?~. These results demonstrate an antagonizing bi-functional 
positive feedback loop in which th'e accumulation of cellular NRAGE enhance 
progression through the cell cycle in a p38 dependent manner, concurrently 
stimulating Smad dependent cell cycle withdrawal. Collectively these results 
demonstrate that NRAGE facilitates apoptosis in a cell cycle dependent manner 
leading to the accumulation and activation of p53. 
NRAGE is  Required for the Cell Cycle Arrest and Differentiation of 
Multipotent Progenitors. 
Terminal differentiation of post-mitotic neurons required exit from the cell 
cycle with increasing evidence Rb family members function as key regulators. 
Failure to exit the cell cycle at the appropriate time leads to apoptosis. This 
coupled relationship between cell cycle and differentiation is modulated at 
multiple stages during the development to mature cells and the aberrant 
deregulation of Rb during NRAGE cell cycle withdrawal suggests that NRAGE 
plays a key role as a regulator of terminal differentiation and apoptosis. Taking 
advantage of the differentiative potential of P I 9  cells, antisense NRAGE 
morpholinos or control morpholinos were used to knockdown NRAGE protein 
expression. Cells were then differentiated with RA to induce neurogenesis and 
the percentage of post-mitotic neurons was calculated using MAP2alb 
expression, astrocytes were detected by GFAP expression and proliferative 
multipoint neural progenitors by nestin. Loss of NRAGE expression drastically 
perturbed the generation of neurons and this deficit appeared to be the result of a 
failure of neural progenitor cell cycle withdrawal (Figure 19A). 
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Figure 19. NRAGE Mediates the Transition of Multipotential Neural 
Progenitors to Post-mitotic Neuron. 
(A) PI9 embryonal carcinoma control or NRAGE knockdown cells were 
differentiated with RA for 4 days and then cultured for an additional 4 days 
without RA. Then subsequently stained for the post-mitotic neuron marker 
MAP2a/b, the glial marker GFAP and nestin for multipotential neural progenitors. 
In the absence of NRAGE post-mitotic neurons failed to be generated and this 
deficit resulted in the accumulation of neural progenitors. Glial differentiation 
remained unaffected. To assess whether the inhibition was a resulted of 
perturbation in pro-neural gene expression RT-PCR was performed on RA 
stimulated control and NRAGE knockdown cells cultured as aggregates between 
1-4 days. (B) Both Oct314 and Hesl gene expression were elevated suggesting 
NRAGE knockdown cells remain as pluripotent neural progenitors. Interesting, 
loss of NRAGE did accelerates the onset of early pro-neural gene expression 
and BMP regulated genes. However, the expression of later pro-neural gene 
expression like MEF2A and MEF2C was abolished. Collectively, these results 
demonstrate the requirement for .NRAGE to mediate the transition of neural 
progenitor to post-mitotic neuron. 
The deficit was at the sole expense of neurogenesis as evident by an increase of 
32 5 5% in the number of multipotent progenitors with the ratio of glia remaining 
unaffected. Therefore, NRAGE appears to be a key component regulating the 
transition of multipotent progenitors to differentiated phenotype. 
To determine whether this inhibition in differentiation was a direct result in 
failure to induce appropriate gene expression RNA was collected on days 1 
through 4 of differentiation and semi-quantitative RT-PCR was performed. During 
RA treated cultures NRAGE knockdown did not inhibit the induction of pro-neural 
gene expression (Figure 19B). In fact the loss of NRAGE accelerated RA 
regulated gene expression by 24 hours. Furthermore, using Oct314 as a general 
measure of the state of "sternness" and Hesl as a determinant of the frequency 
of neural progenitors, NRAGE knockdown cells appeared to expand or maintain 
cells in a multipotent state. This enhanced neurogenic gene expression is in 
agreement with data obtained from neurogenesis of ES as a direct result of 
prolonged Oct314 expre~sion~'~ and loss of p38 activity4". Therefore, the 
apparent incapacity to generate post-mitotic neurons in NRAGE knockdown cells 
is not a deficit in early pro-neural gene expression per se, but may reflect an 
imbalance between early pro-neural genes and antagonistic bHLH factors like 
Hesl and Hes5. Indeed, Hesl levels are elevated to inappropriate levels as a 
result of loss of NRAGE (Fig. 196). This imbalance may directly contribute to the 
loss of late neurogenic genes like MEF2NC as NRAGE knockdown greatly 
perturbs the genesis of these transcription factors (Fig. 19B). Whereas, 
MEF2BlD transcription factors, which are not involved in neural progenitor 
differentiation, their gene expression remain unaffected by NRAGE knockdown 
(data not shown). Importantly, MEF2NC has been shown to be an absoll~te 
requirement regulating both myogenesis and neurogenesis in a cell cycle 
dependent manner408410. The loss of MEF2C is arguably a contributing factor 
associated with the neurogenic deficit. Taken with the demonstration that 
NRAGE is a potent regulator of the cell cycle, we conclude that the neurogenic 
deficit is a result of failure to generate post-mitotic neuron in an NRAGE-cell- 
cycle dependent manner. 
To further corroborate our finding we challenged sorted IvRAGE'~~' or 
control'GFP expressing cells to differentiate in the presence of RA. As NRAGE is 
a potent inducer of apoptosis we maintained our cultures in the presence of the 
specific caspase-3 inhibitor Z-DQMD-FMK. The overall level of neurogenesis 
was reduced for both our cultures, suggesting a basal level of active caspase-3 is 
required for the transition of stem cell to neural stem cell, however this inhibition 
was not absolute. In agreement with a pro-neural contribution, IVRAGE over- 
expression significantly enhanced the number of post-mitotic neurons generated 
and this increase in neurogenesis cooperatively reduced the neural progenitor 
pool (Fig. 20). 
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Figure 20. NRAGE Over-expression Facilitates Neurogenesis 
IVRAGE-GFP and GFP EC cells were sorted by FACS and differentiated 
under standard RA conditions. As NRAGE over-expression is highly apoptotic 
cultures were maintained in the presence of a specific caspase-3 inhibitor. Note 
the enhanced neurogenesis as consequence of NRAGE over-expression. The 
increase in NRAGE drives NP out of the cell cycle early and thus reduces the 
overall number of NP present. 
Therefore our results collectively demonstrate that NRAGE is required for the 
terrr~inal differentiation of neural progenitors to post-mitotic neuron and inhibition 
of NRAGE activity is fatal to neurogenesis. However, NRAGE levels and activity 
must be strictly regulated as failure to so quickly changes NRAGE from a pro- 
differentiation to pro-apoptotic molecule. 
Discussion 
The presence of apoptosis in the proliferative neuroepithelium raises the 
question of how the balance between maintenance and depletion of the 
progenitor pool size is appropriately controlled by the extracellular 
environment346. To elucidate the specific features of neural progenitor apoptosis 
during neocortical development, we took advantage of primary cortical 
progenitors and the PI9 cell line. PI9 cells differentiate into neurons and glia 
when grown in the presence of RA4I1. In addition to differentiation, RA also 
induces activation of caspase-9 and 3 promoting apopt~s is~ ' * -~ '~ .  Furthermore, 
the apoptotic action of RA is facilitated by the addition of BMP2 or 
The actions of RA mediate apoptosis through the RA receptor a and y417, which 
418.419 promote the transcription of BMP2 and BMP4 . 
In this study, we shown that NRAGE is a necessary and sufficient 
mediator of RAlBMP induced apoptosis in both cortical progenitors and PI9 
cells. The RAlBMP apoptotic signal requires the activation of BMPR-la and 
subsequent formation of an NRAGE signaling complex involving XIAP, TAKI and 
TABI. NRAGE, which has been shown in the peripheral nervous system to 
mediate cell cycle withdrawal and cell survival, is here shown to also 
take part in BMP regulation of progenitor cell number in the forming cortex. 
NRAGE functions to mediate apoptosis by forming a complex with members of 
the non-canonical BMP signaling cascade TAKI, TAB1 and XIAP. This 
interaction leads to serine phosphorylation of NRAGE and activation of p38 and 
the caspase cascade leading to cell death. NRAGE plays a vital role in this 
pathway in that forced activation of NRAGE by over-expression leads to caspase 
and p38 activation and apoptosis, whereas, eliminating or diminishing NRAGE 
expression rescues cell viability in the presence of BMP. This places NRAGE as 
a mediator in determining cell death in these progenitor systems. 
XIAP as a Mediator of Cell Death 
Since NRAGE is shown to be an activator of p38 that ultimately initiates 
the cell death program, the question shifts to how is NRAGE regulated and 
activated within the cell. NRAGE binds both TAKI and TAB1 leading to NRAGE 
serine phosphorylation and ultimately initiation of apoptosis. This suggests that 
NRAGE is a f~~lcrum between apoptosis and survival and that when associated 
with TAKI and TABI, NRAGE triggers death but regulated by contact with XIAP. 
Therefore, unlike neurotrophin survival in which cells are at the brink of death 
and compete for limited amounts of trophic support to quench the apoptotic 
signals, BMP induced cell death is an instructive signal initiating a quiescent 
apoptotic pathway. 
Early Progenitor Cell Death 
There appears to be two functionally distinct types of programmed cell 
death in the developing nervous system of mammals. An early cell death limiting 
the number of neural precursors and the more traditional mechanism of pruning 
unnecessary and miss-routed post-mitotic neurons based on trophic support16. 
Upper reports have suggested that up to 70% of cortical neuroblasts in the 
proliferative ventricular zone undergo apoptosis, though the actual percentage 
conceptually must be less than 50% in order to expand the neural epithelium. 
Whatever the exact percentage is in murine and primate species this progenitor 
apoptosis cornmences at E10, and peaking at -E13, before decreasing 
postnatally to low levels seen in the adult23s26s29*342*343. This early-programmed cell 
death coincides well with both the spatial and temporal distribution of NRAGE. 
Given the evidence presented within, it seems logical that this early cell death is 
mediated by the activa,tion of INRAGE by BlVlPs and potentially other TAKI, TAB1 
activating factors, resulting in p38 activation and initiation of the caspase. Taken 
together with the fact that NRAGE levels peak just prior to the onset of the 
apoptosis described by Blaschke et al. This further supports the important role 
that NRAGE plays in mediating cell survival in the early cortex. 
NRAGE is a Required Element in Cell Cycle Withdrawal, Differentiation and 
Apoptosis of Neural Progenitors. 
Our findings presented within are in agreement with previous reports 
demonstrating a collaborative effort between TAKI and TAB1 induced cell death 
in the ventralization the Xenopus embryo2I4. The activation of TAKI requires an 
association with TABI~*'. Moreover, XlAP interaction with the cytoplasmic 
domain of BMPR-la enhanced the ventralization of TABI-TAKA, but perturbed 
the apoptotic There is increasing evidence that this pro-apoptotic effect 
is directly regulated by p38, not JNK activity, which antagonizes the survival 
effects of FGF8-MAPK signaling required for neural progenitor survival 421 -424 
Abrogation of NRAGE or TAKI expression leads to a decreased in p38 activation 
and reduced cell death. It is tempting to speculate that the capacity for p38 to 
challenge cells to undergo apoptosis is regulated in part by its ability to directly 
phosphorylate Rb in a cdk independent manner399b401. In this context p38 can 
direct cells through the cell cycle leading to an enhanced G2-M arrest as a result 
of active E2F-1 cell cycle However, when NRAGE levels exceed a 
specific cell context dependent threshold hlRAGE transitions from regulating 
required cell signaling needed to mediate cell cycle withdrawal to facilitating 
apoptosis of neural progenitors through cooperative actions of the apoptosis and 
cell cycle machinery. 
In addition to the capacity for p38 to regulate Rb inactivation, p38 
stimulates myocyte enhancer factor 2 (NIEF2) family of transcription factors, 
specifically MEF2A and IWEF2C, not MEF2B or M E F ~ D ~ ~ ~ - ~ ~ ~ .  MEFs are 
members of the MADS family of transcription factors originally identified as key 
regulators directing myogenesis. They appear to function by physically 
interacting with the basic helix-loop-helix (bHLH) myogenic transcription factor 
MyoD and myogenin to promote muscle Furthermore, 
MEF2A and C are highly expressed in developing neural progenitors4I0 and 
cooperate with the pro-neural bHLH transcription factor Mash1 during 
n e u r ~ g e n e s i s ~ ~ ' - ~ ~ ~ ,  which is in agreement with our findings that NRAGE 
knockdown prevents the transition of progenitor to post-mitotic neuron potentially 
due in part to deficient MEF2AJC activation. During myogenesis the MEF2C- 
MyoD complex requires the hypophosphorylated or active form of Rb as an 
integral component to direct muscle development434 and failure to so results in a 
p2lwaf1-dependent apoptosisa5. Over activation of p38 leads to in excess of the 
hyperphosphorylated Rb incapable of functioning in the MEF2-MyoD complex 
promoting unscheduled re-entry into the cell cycle leading to apoptosis, whereas 
insufficient p38 activity fails to generate adequate levels of active MEF2C 
transcription factors thereby preventing the generation of the MEF2-MyoD 
complex inhibiting differentiation of progenitor cells. Similar effects of p38 activity 
are evident in our NRAGE gain and loss-of-function studies that demonstrate the 
capacity for NRAGE to regulate the pleiotropic functions of p38 that ultimately 
govern neurogenesis. 
NRAGE Functions as an Important Link Between Differentiation and 
Apoptosis. 
Though there is no direct evidence to date that Rb binds and function as a 
complex with MEF2-Mash1 transcription factors in neural progenitors, sufficient 
circumstantial evidence exists that suggests a similar mechanism that directs 
myogenesis may regulate neurogenesis. Neural progenitor undergoing BMP 
mediated apoptosis require elevated p21 and p27kip1 
Furthermore, accumulation of non-apoptotic levels of p27kip1 is required for BMP- 
induced growth arrest and neural that is integrally linked to 
the activity MEF2C and Rb promoting survival under stringent p38 
activity271 ,437,438 
CHAPTER 4 
General Conclusions. 
A requirement for neural progenitor differentiation is exit from the cell cycle 
in which several proteins have been implicated in controlling the G I  arrest, one 
of which Necdin is a close family member to N R A G E ' ~ ~ * ~ ~ ~ - ~ ~ ~ .  Direct coupling of 
the cell cycle and death machinery regulating differentiation has been well 
documented693440. Unrestrained E2F activity as a result of loss of Rb function and 
forces unscheduled re-entry into the. S phase of neural progenitors attempting to 
arrest in G I ,  thereby promoting apoptosis through p53. The importance for Rb in 
maintaining the G I  arrest and thus cell survival becomes very apparent in ~ b - l -  
null mice in which aberrant S phase re-entry results in a tremendous level of 
63-66 apoptosis in the progenitor pool leading to embryonic lethality by E15.5 . 
Though this apoptosis can be circumvented in conditional ~ b - ' -  null mice under 
the control of the Foxgl promoter441 and explained in lieu of a model proposed 
by Gail  arti in^^^ in which FGF8 activates the transcription factor Foxgl that 
inhibits BMP mediated apoptosis in neural progenitors. Our gain and loss-of- 
NRAGE studies support the pinnacle roll, which Rb plays in maintaining survival 
and differentiation of neural progenitors and positions p38 as a molecular switch 
determining life or death. 
Furthermore, the results presented within demonstrate that perturbation of 
BMP signaling through NRAGE knockdown enhances both pro-neural and anti- 
neural gene expression. This imbalanced gene expression, a direct result of loss 
of p38 activity leading to prolonged .0ct314 and Hesl expression, is sufficient to 
permit the transition from pluripotent stem cell to neural progenitor. However, 
when these progenitors are challenged to differentiate into a post-mitotic cell, in 
addition to cell cycle deficit's, they lack sufficient levels of MEF2AIC, which is an 
integral component required to drive the later stages of neurogenesis. Should a 
progenitor be exposed to high levels of BMP stimulation, NRAGE sustains 
proliferation and re-entry into the cell cycle through direct yet transient coupling 
of Rb phosphorylation by p38 kinase activity, which is functionally antagonized 
via a prolonged Smad-NRAGE inhibition of c-myc and activation of p21Waf1 and 
p27kipl 403-405 
. These apposing challenges on the cell cycle, all regulated ,through 
BMPR, when in excess lead to the promotion of an NRAGE-p53 dependent 
apoptosis. Therefore, NRAGE has the capacity to regulate progression through 
the cell cycle and cell cycle arrest in an elegant cell context dependent manner 
ultimately affecting the overt differentiation of the progenitor pool creating a 
differentiation-coupled apoptosis (Fig. 21). 
Figure 21. NRAGE Mediates Apoptosis of Neural Progenitors. 
BNlP stimulation triggers activation of NRAGE and its cooperation with the 
XIAP-TAKI-TAB1 complex to activate p38. Active p38 directly inactivates Rb, 
thus promoting progression through the cell cycle. This precocious re-entry into S 
phase leads to the activation of p53 that simultaneously facilitates activation of 
p21Waf1, promoting growth arrest and formation of the apoptosome resulting in 
mitochondria1 leakage and caspase activation. The requirement for NRAGE 
mediated growth arrest i s  best demonstrated through loss of function in which 
neural progenitors fail to differentiate, as terminal exit from the cell cycle is 
perturbed. 
However, crosstalk of the BMP signaling pathway with other signal transduction 
pathways is becoming increasing more robust. Reciprocal modulation has been 
described between Wnt (canonical and non-canonical), TGF-blactivin, Erk-MAPK 
and the JAK-STAT pathway. An understanding of biological context in which 
these signaling pathways intersect signifies the next major frontier. It is of 
paramount importance to define NRAGE's role within this greater context of cell 
biological signaling. 
Wnt and BMP Siqnalinq Durinq Neuroqenesis. 
Although a role for Wnt signaling in early dorsal-ventral patterning is well 
established, Wnt signaling has only recently been shown to contribute to neural 
induction and cell survival 443.444. The Wnt signaling cascade includes the 
secreted Wnt ligands, Frizzled receptors, and intracellular proteins such as 
Dishevelled and glycogen synthase kinase 3 (GSK3). After activation of the Wnt 
signaling pathways, GSK3 inhibition by Dishevelled allows stabilization and 
nuclear localization of 0-catenin, complexes with TCF DNA-binding proteins to 
activate transcriptional targets445. 
Ectodermal explants from Xenopus can be induced to form 
neuroectoderm through Wnt treatment or over-expressing the Frizzled receptor, 
Dishevelled, a dominant negative form of GSK3 or a constitutively active form of 
p - ~ a t e n i n ~ ~ ~ .  However, .the most compelling data suggesting an important in vivo 
role for Wnt signaling comes from mouse models over-expressing a constitutively 
active form of p-catenin in the ectoderm resulting in expansion of the neural 
progenitor pool, whereas a dominant-negative form of TCF blocks neural tissue 
formation and promotes a p o p t ~ s i s ~ ~ ~ .  Although it is not yet certain how Wnt 
signaling exerts in neurulizing activity, this process may be mediated by 
regulation of BMP expression. As noggin cannot down-regulate BMP4 
expression during gastrulation, Wnt signaling can perform this function443. In 
Xenopus, it has been suggested that the neural specifier (Xirol and Xiro2) that is 
activated by Wnt signaling encodes a repressor that is essential for neural 
development by down regulating B M P ~ ~ ~ ~ .  In zebrafish, Wnt signaling seems to 
play a more central role in neural patterning than in neural induction. Mutations in 
the Wnt signaling pathway include headless (TCF3) and bozozok, a 
homeodomain protein downstream of Wnt signaling448450. Embryos carrying 
mutations in either of these genes have defects in anterior-posterior neural 
patterning, but neural tissue is still induced. However, Wnt signaling is carefully 
regulated and Wnt antagonists are needed to promote telencephalic 
development of the ANR. One of the secreted proteins responsible for the activity 
of the ANR is  TIC^^', a member of the secreted Frizzled Related Proteins (sFRP) 
family. sFRPs are generally considered to antagonize Wnt activity by 
sequestering secreted ~ n t s ~ ~ * .  This suggests that the establishment of the 
telencephalon requires local suppression of Wnt activity. Studies in Xenopus, 
chick and mouse also suggest that the telencephalon is established in a domain 
of low Wnt a ~ t i v i t y ~ ~ " ~ ~ ~ .  The canonical Wnt pathway is used reiteratively during 
the development of the forebrain. Wnt signaling contributes to initial 
regionalization of the formation neural plate into crude AP subdivisions, then 
locally promotes caudalization of the forebrain anlage and later still induces 
proliferation and modulates patterning within individual forebrain domains. 
Although these roles are now reasonably well documented, the mechanisms by 
which Wnt and BMP signaling regulates regional fate determination within the 
forming CNS are still poorly understood. However, there is evidence that BMP 
and Wnt/p-catenin signaling directly interact in early Xenopus embryos, TAKI 
activates a distantly related MAPK family member Nemo-like kinase (NLK); this 
pathway culminates in the inhibitor phosphorylation of TCF-l/Lef-1 and the 
down-regulation of Wntlp-catenin-inducible trans~ription~'~,~~'. Therefore, it is 
tempting to speculate that in addition to NRAGE-TAKA-p38 activity, NRAGE may 
antagonize Wnt signaling through. direct coupling of NRAGE and NLK. Indeed, in 
Drosophila and Xenopus, NLK is required for BMP mediated neurogenesis and 
a p o p t o s i ~ ~ ~ ~ ~ ~ ~ ~ .  Thus, these novel insights provide yet an additional level of 
BMP-NRAGE mediated regulation of neurogenesis to explore. 
FGF and BMP Siqnalinq During Neurogenesis. 
The ability of Wnt antagonists to locally induce instructive FGF signals in 
the A N R ~ ~ '  suggests that establishment of the ANR, as a source of FGF signals 
is a downstream consequent of local repression of Wnt activity. Secreted FGFs 
signal to target cells by binding and activating cell-surface tyrosine kinase FGF 
receptors ( F G F R S ) ~ ~ ' ~ ~ ~ ~ .  Once an FGF ligand is bound, the receptor dimerizes 
and phosphorylates intermolecular tyrosine residues, triggering initiation of FGFR 
signal t r a n s d u ~ t i o n ~ ~ ~ ~ ~ ~ .  FGFR signaling activates a number of signal 
transduction molecules, including those of the Ras-ERK and phospholipase C-y 
pathways 464.466-468 
One of the most intriguing roles proposed for FGFs signals is to polarize 
the telencephalon, with high levels of FGF activity promoting anterior cortical 
fates4691470. Specially, following neural tube closure, Fgf8 expression is localized 
to the ANR '~~ . ' ~ '  and removal of the ANR or treatment with inhibitors of FGF 
signaling causes loss of expression of telencephalic molecular markers, such as 
Foxg 1 (B~ I ) '~ '~~~ '  . More recently, through genetically elimina.ting, genetically 
reducing or experimentally increasing Fgf8 expression in the forebrain a dose 
dependent effect on cell differentiation and survival was observed442. In 
particular, either eliminating or increasing Fgf8 expression increased apoptosis, 
whereas reducing Fgf8 expression had the opposite effect and these result 
where attributed to changing BNIP4 levels. In the telencephalon, FGF activity 
may contribute to the polarization of the cortical territories in part through 
repression of Emx2 transcription The competence of adjacent 
cells to respond to FGF signals may both be regulated by Six3 and Irx proteins. 
Fgf8 expression in the ANR is dependent on Six3 and in a similar 
way to Six3, Otx2 may confer the ability of the anterior neural plate to respond to 
ANR signals. Indeed, the ANR of hypomorphic otx2 mutant mice is functionally 
intact, but the neural plate of such embryos lacks the ability to respond to ANR 
signals or exogenous F G F S ~ ~ ~ .  
The ability of FGF signaling to regulate regionalization of the 
telencephalon through suppression of high levels of BMP activity is an important 
step in the establishment of the prospective forebrain475. However, with the 
forming neural plate, lower levels of BMP activity contribute to the initial 
establishment of the lateral to medial pattern. Consequently, specific thresholds 
of BMP activity appear to be required for the commitment of fates that derive 
from margins of the neural plate, such as telencephalon, dorsal eye, and 
epithalamus r o s ~ t r a l l y ~ ~ ~ , ~ ~ ~  and dorsal sensory neurons and neural crest cells 
These observations suggest that a window of BMP activity during 
neurogenesis enables development of marginal and dorsal neural fates. If BMP 
signaling is too high, non-neural fates are promoted, whereas if it is too low, then 
more medial neural plate fates are promoted. Thus establishment of the ANR 
itself may depend upon rostra1 marginal neural plate cells being exposed to 
appropriate levels of BMP Indeed, the capacity for cortical 
progenitors within the CNS to respond to BMPs is highly dependent on their 
developmental age. During early neurogenesis of the cortex, E12, BMP4 
promotes apoptosis 3830481n482. Intriguingly, by E l 4  low doses of BMP4 are 
required to promote neurogenesis within the dorsal neocortex and as the 
concentration of BMP4 increases neural progenitors have a greater propensity 
towards apoptosis This BMP4-mediated apoptosis of early neural 
progenitors is dependent on the transcription factors Msx2, ID2 and the CKI 
~2 1 Waf1436 . Collectively, these studies demonstrate that BMP4 is an important 
switch between cell death and differentiation in a cell cycle dependent manner. 
The capacity for FGFs to regulate the survival and differentiation of neural 
progenitors is believed to occur through inhibition of excessive BMP signaling. 
The ERK-MAPK pathway that mediates the effects of certain receptor tyrosine 
kinases (RTKs) can also modulate the BMP-Smad pathway by regulating Smad 
activity. Activation of RTKs by libands such as FGF or EGF stimulates ERK 
mitogen-activated protein kinases. ERK in turn phosphorylates serine residues in 
consensus PXSP motifs located within the MH1 and MH2 domains of ~ m a d 1 ~ ~ ~ .  
This phosphorylation serves to inhibit nuclear accumulation of Smadl, although 
the mechanism for this inhibition remains unclear. This mechanism may underlie 
the observed opposing effects of mitogenic factors and BMPs during 
development4847485, thereby preventing growth arrest through perturbation of 
nuclear translocation of NRAGE-Smad complexes. However, BMP and FGF 
signaling can cooperate in certain contexts, such as bone and tooth 
morphogenesis and erythroid differentiation 486-489 
The Smads are sometime referred to as "fast-track" molecules because 
they can directly transduce a signal from the plasma membrane to the gene. The 
JAK-STAT pathway also uses "fast-track" molecules, namely the STATS~". 
Recently, evidence for cross talk between these two pathways has been 
reported. Leukemia inhibitory factor (LIF), which acts through the gp130 receptor 
and STAT3, can act synergistically with BMP2 in inducing astrocyte 
This synergism has been shown to be due to the formation 
of a Smadl and STAT3 complex bridged by the transcriptional co-activator 
p300lCBP. Moreover, the synergistic effect of BMP4 and LIF, was recently 
described as a mechanism for embryonic stem cell self-renewal through 
antagonization of ERK and inhibition of TAKI-mediated activation of p38, that 
consequently leads to the up-regulate of helix-loop-helix (HLH) inhibitor of 
differentiation (Id) transcription factors and MSX~~' ' .  A phenomenon recapitulated 
in our NRAGE knockdown paradigm in which perturbation of NRAGE and thus 
p38 activity was sufficient to trap NP in an undifferentiated state. The concept for 
BMP facilitating stem cell self-renewal also applies to neural stem cells. In the 
place of LIF signaling, activation of Notch plays a key role in keeping progenitor 
cells from differentiating into neurons. BMP2 was shown to enhance neural 
progenitor cell maintenance through Notch-induced transcriptional activation of 
the basic-helix-loop-helix (bHLH) transcription factor Hesl and Hes5 in which 
Smadl and IVotch intracellular domain complex with p300 promoting progenitor 
gene t rans~r ip t ion~~~.  Collectively these results highlight the increasing 
awareness of the important contributions that HLH and bHLH transcription 
factors play in the differentiation of neural proger~itor cells and the complex cross 
talk mediated through BMPRs in which NRAGE regulating both growth arrest and 
cell cycle progression ultimately affect the capacity of overt differentiation. Thus, 
our results yield novel insights in the dynamic interplay NRAGE regulates 
through BMP signaling directing stem cell self renewal, differentiation and 
survival. 
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